DS Healthcare (DSKX) 10-Q 14 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 12, 2013
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Entity Registrant Name	'DS HEALTHCARE GROUP, INC.	'
Entity Central Index Key	'0001463959	'
Current Fiscal Year End Date	'--12-31	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2013	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Units Outstanding	'	13,768,326

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current Assets	'	'
Cash	$763,957	$412,488
Accounts receivable, net	1,802,262	2,125,641
Inventory	2,562,399	3,453,950
Prepaid expenses and other current assets	260,205	159,164
Total Current Assets	5,388,823	6,151,243
Furniture and Equipment, net	232,524	293,720
Advances to Affiliates	'	17,973
Intangible assets, net	1,488,712	1,674,852
Other Assets	75,265	86,888
TOTAL ASSETS	7,185,324	8,224,676
Current Liabilities	'	'
Accounts payable	2,287,625	2,327,540
Accrued expenses	441,551	704,882
Client facility	576,088	448,658
Shareholder loans	21,700	353,000
Other current liabilities	300,817	227,407
Total Current Liabilities	3,627,781	4,061,487
Long Term Debt	37,143	45,177
TOTAL LIABILITIES	3,664,924	4,106,664
COMMITMENTS AND CONTINGENCIES	'	'
Equity	'	'
Preferred stock, $0.001 par value, 30 million shares authorized: 0 and 5,500,000 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively	'	5,500
Common stock, $0.001 par value, 300 million shares authorized: 13,759,383 and 12,119,705 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively	13,759	12,120
Additional paid-in-capital	10,942,093	9,244,748
Stock subscription	-27,500	-30,000
Accumulated deficit	-7,366,453	-5,097,990
Accumulated comprehensive income	-13,167	'
Total Shareholders' Equity	3,548,732	4,134,378
Non-Controlling Interest	-28,332	-16,366
Total Equity	3,520,400	4,118,012
TOTAL LIABILITIES AND EQUITY	$7,185,324	$8,224,676

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Condensed Consolidated Balance Sheets [Abstract]	'	'
Preferred stock, par value per share	$0.00	$0.00
Preferred stock, shares authorized	30,000,000	30,000,000
Preferred stock, shares issued	0	5,500,000
Preferred stock, shares outstanding	0	5,500,000
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	13,759,383	12,119,705
Common stock, shares outstanding	13,759,383	12,119,705

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue:	'	'	'	'
Product sales	$3,338,751	$3,348,016	$11,422,939	$9,261,091
Less allowances	-138,562	-157,626	-829,904	-588,457
Net revenue	3,200,189	3,190,390	10,593,035	8,672,634
Cost of Goods Sold	1,437,763	1,399,007	5,454,840	4,380,170
Gross Profit	1,762,426	1,791,383	5,138,195	4,292,464
Selling and marketing:	'	'	'	'
Commissions and consulting	463,106	341,513	948,146	1,041,048
Other selling and marketing expenses	718,791	620,700	1,885,116	1,495,149
Total selling and marketing	1,181,897	962,213	2,833,262	2,536,197
General and administrative	'	'	'	'
Salary and personnel costs	488,113	410,854	1,446,789	1,009,681
Professional fees and consulting costs	419,180	201,624	1,157,566	909,966
Other general and administrative expenses	455,048	268,026	1,636,220	690,343
Total general and administrative	1,362,341	880,504	4,240,575	2,609,990
Total operating costs and expenses	2,544,238	1,842,717	7,073,837	5,146,187
Operating Loss	-781,812	-51,334	-1,935,642	-853,723
Other Income (Expense)	'	'	'	'
Loss on conversion of debt	-289,600	'	-289,600	'
Interest income	'	698	'	1,474
Interest expense	-23,327	-17,179	-84,888	-27,363
Other	23,357	27,451	24,018	30,826
Total other income (expense)	-289,570	10,970	-350,470	4,937
Loss Before Taxes	-1,071,382	-40,364	-2,286,112	-848,786
Income Tax (Benefit)	-16,571	'	-5,683	'
Net Loss	-1,054,811	-40,364	-2,280,429	-848,786
Net Loss Attributable to Non-Controlling Interest	-1,405	'	-11,966	'
Net Loss Attributable to Shareholders	-1,053,406	-40,364	-2,268,463	-848,786
Basic and Diluted Earnings per Share:	'	'	'	'
Weighted average shares	12,557,240	11,202,792	12,303,089	10,778,475
Loss per share	($0.08)	$0	($0.18)	($0.08)
Other Comprehensive Income:	'	'	'	'
Foreign currency translation adjustment	-18,754	'	-13,167	'
Comprehensive loss	($1,072,160)	($40,364)	($2,281,630)	($848,786)

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Changes in Equity (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid In Capital [Member]	Subscription/Stock Receivable [Member]	Accumulated Deficit [Member]	Other Comprehensive Income [Member]	Total Shareholders' Equity [Member]	Non-Controlling Interest [Member]
Balance at Dec. 31, 2011	$5,005,246	$10,000	$10,503	$6,606,668	($100,000)	($1,506,893)	'	$5,020,278	($15,032)
Balance, shares at Dec. 31, 2011	'	10,000,000	10,502,961	'	'	'	'	'	'
Shares Issued:	'	'	'	'	'	'	'	'	'
Sold to private investors	732,000	'	292	731,708	'	'	'	732,000	'
Sold to private investors, shares	'	'	292,000	'	'	'	'	'	'
Less: Issuance costs	-146,400	'	'	-146,400	'	'	'	-146,000	'
For services	'	'	'	'	'	'	'	'	'
Investor relations	307,394	'	105	237,289	70,000	'	'	307,391	'
Investor relations, shares	'	'	104,697	'	'	'	'	'	'
Employee/associate compensation	158,915	'	58	158,857	'	'	'	158,915	'
Employee/associate compensation, shares	'	'	58,249	'	'	'	'	'	'
Distributor award	234,139	'	79	234,060	'	'	'	234,139	'
Distributor award, shares	'	'	78,704	'	'	'	'	'	'
Consulting	4,000	'	2	3,998	'	'	'	4,000	'
Consulting, shares	'	'	2,000	'	'	'	'	'	'
Purchase Mexican distributor	1,303,000	'	600	1,302,400	'	'	'	1,303,000	'
Purchase Mexican distributor, shares	'	'	600,000	'	'	'	'	'	'
Purchase of brand rights	2,879	'	'	'	'	'	'	'	'
Fractional shares from reverse split	50,000	'	9	'	'	'	'	'	'
Shares Cancelled / Surrendered:	'	'	'	'	'	'	'	'	'
Issued in error and returned	-56,000	'	-20	-55,980	'	'	'	-56,000	'
Issued in error and returned, shares	'	'	-20,000	'	'	'	'	'	'
Surrendered	-16,800	'	-5	-16,795	'	'	'	-16,800	'
Surrendered, shares	'	'	-5,000	'	'	'	'	'	'
Warrants and Options:	'	'	'	'	'	'	'	'	'
Vested for trading symbol	128,000	'	'	128,000	'	'	'	128,000	'
Exercised	4,070	'	41	4,029	'	'	'	4,070	'
Exercised, shares	'	'	40,700	'	'	'	'	'	'
Conversion of preferred shares to common stock	'	-4,500	450	4,050	'	'	'	'	'
Conversion of preferred shares to common stock, shares	'	-4,500,000	450,000	'	'	'	'	'	'
Disposal of Brazil distribution joint venture	30,679	'	'	'	'	15,647	'	15,647	15,032
Net Loss	'	'	'	'	'	-3,606,744	'	-3,606,744	-16,366
Balance at Dec. 31, 2012	4,118,012	5,500	12,120	9,244,748	-30,000	-5,097,990	'	4,134,378	-16,366
Balance, shares at Dec. 31, 2012	'	5,500,000	12,119,705	'	'	'	'	'	'
Shares Issued:	'	'	'	'	'	'	'	'	'
Sold to private investors	406,300	'	381	413,419	-7,500	'	'	406,300	'
Sold to private investors, shares	'	'	381,192	'	'	'	'	'	'
Less: Issuance costs	-31,260	'	'	-31,260	'	'	'	-31,260	'
For services	'	'	'	'	'	'	'	'	'
Investor relations	276,550	'	153	276,397	'	'	'	276,550	'
Investor relations, shares	'	'	152,700	'	'	'	'	'	'
Employee/associate compensation	52,721	'	32	52,689	'	'	'	52,721	'
Employee/associate compensation, shares	'	'	31,779	'	'	'	'	'	'
Distributor award	105,723	'	55	105,668	'	'	'	105,723	'
Distributor award, shares	'	'	55,498	'	'	'	'	'	'
Board of Directors	32,350	'	12	32,338	'	'	'	32,350	'
Board of Directors, shares	'	'	12,500	'	'	'	'	'	'
Fractional shares from reverse split	'	'	9	'	'	'	'	'	'
Subscriptions sold, shares not Issued:	'	'	'	'	'	'	'	'	'
Sold to private investors	-10,000	'	'	'	10,000	'	'	-10,000	'
Warrants and Options:	'	'	'	'	'	'	'	'	'
Conversion of preferred shares to common stock	'	-5,500,000	550	4,950	'	'	'	'	'
Conversion of preferred shares to common stock, shares	'	-5,500	550,000	'	'	'	'	'	'
Shareholder loan converted	843,600	'	456	843,144	'	'	'	843,600	'
Shareholder loan converted, shares	'	'	456,000	'	'	'	'	'	'
Other comprehensive income	-13,167	'	'	'	'	'	-13,167	-13,167	'
Net Loss	-2,280,429	'	'	'	'	-2,268,463	'	-2,268,463	-11,966
Balance at Sep. 30, 2013	$3,520,400	'	$13,759	$10,942,093	($27,500)	($7,366,453)	($13,167)	$3,548,732	($28,332)
Balance, shares at Sep. 30, 2013	'	'	13,759,383	'	'	'	'	'	'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash Flows from Operating Activities:	'	'
Net Loss	($2,280,429)	($848,786)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	283,730	177,663
Amortization of deferred issuance costs	47,908	'
Loss on disposal of fixed assets	5,126	'
Provision for doubtful accounts	319,756	82,552
Inventory obsolescence allowance	12,527	'
Stock issued for services	467,345	530,309
Warrants issued for financial services	'	4,070
Warrants issued for other services	'	128,000
Loss on extinguishment of debt	289,600	'
Stock returned and cancelled	'	-56,000
Changes in operating assets and liabilities:	'	'
Accounts receivable	3,622	-769,330
Inventory	879,024	-745,937
Prepaid expenses and other current assets	-148,950	-248,855
Accounts payable	-39,913	387,663
Accrued expenses	-263,330	23,215
Other current liabilities	73,409	49,275
Net cash used in operating activities	-350,575	-1,286,161
Cash Flows from Investing Activities:	'	'
Purchase of furniture and equipment	-41,018	-87,906
Purchase of injection molds	-35,139	-48,287
Proceeds from disposal of fixed assets	20,039	'
Disposal of Brazil Joint Venture	'	4,678
Purchase of brand rights	-4,307	-102,420
Security deposits	10,801	-7,081
Purchase of Mexican customer list	19,727	'
Net cash used in investing activities	-29,897	-241,016
Cash Flows from Financing Activities:	'	'
Net proceeds of credit facility	127,430	602,298
Proceeds from shareholders' loan	310,000	'
Repayment of loans and notes	-95,335	'
Repayments to related parties	17,973	'
Proceeds from sale of stock subscriptions to investors	10,000	'
Proceeds from sale of stock	406,300	732,000
Less issuance costs	-31,260	-146,400
Net cash provided by financing activities	745,108	1,187,898
Effect of exchange rate changes on cash	-13,167	'
Net Increase (Decrease) in cash	351,469	-339,279
Cash, Beginning of Period	412,488	1,284,343
Cash, End of Period	763,957	945,065
Supplemental Information:	'	'
Cash paid for interest	'	25,995
Cash paid for taxes	'	'
Supplemental Noncash investing and financing activities;	'	'
Stock issued for purchase of Mexican distributor	'	1,500,000
Conversion of shareholder loans to equity	843,600	'
Conversion of preferred shares to common shares	$5,500	'

ORGANIZATION_AND_NATURE_OF_BUS

ORGANIZATION AND NATURE OF BUSINESS	9 Months Ended
	Sep. 30, 2013
ORGANIZATION AND NATURE OF BUSINESS [Abstract]	'
ORGANIZATION AND NATURE OF BUSINESS	'
	NOTE 1. - ORGANIZATION AND NATURE OF BUSINESS
	Terms and Definitions
		AICPA	American Institute of Certified Public Accountants
		ASC	Accounting Standards Codification
		ASU	Accounting Standards Update
		FASB	Financial Accounting Standards Board
		FIFO	First-in, First-out
		US GAAP	Accounting principles generally accepted in the United States of America
		IFRS	International Financial Reporting Standards
		SEC	Securities Exchange Commission
		SFAS or FAS	Statement of Financial Accounting Standards
		2013-QTR	Three months ended September 30, 2013
		2013-YTD	Nine months ended September 30, 2013
		2012-QTR	Three months ended September 30, 2012
		2012-YTD	Nine months ended September 30, 2012
		VIE	Variable Interest Entity
	Organization and Nature of Business
	DS Healthcare Group, Inc. (d/b/a DS Laboratories) (the "Company", "DS Laboratories", "DSKX", "we", "us" or "our") was organized under the laws of the State of Florida in January 2007. Through its predecessors, the Company has been developing and marketing hair care, skin care and personal care products for over fifteen years. The Company has grown steadily over the last few years with a network of top specialty retailers and distributors throughout North America, Europe, Asia and South America. The Company researches and develops its own products, which management believes keeps the Company at the forefront of innovation. Management believes the Company is currently a leading innovator of "Liposome Technology", which acts as a carrier agent, and has been designed to enhance the action of the active ingredients in our products. We currently offer products are within the following broad product categories:
	·	Hair Care
	·	Skin Care
	·	Health and Personal Care
	History of the Company
	The Company was incorporated in January 2007 and capitalized with the assets recovered from a terminated predecessor New York corporation. DS Laboratories, Inc. (a Florida corporation) was also incorporated in January 2007. The companies were founded by common shareholders.
	In the first quarter of 2009,
	·	the Company acquired 100% of the outstanding shares of DS Laboratories, Inc. (a Florida corporation) and Sigma Development and Holding Co., Inc. (a Florida corporation) ("Sigma"), both for a nominal amount. DS Laboratories has been idle since its inception in 2007.
	·	Sigma was founded as an upscale brand addition to the Company's product portfolio.
	·	Polaris Labs, Inc. (a Florida corporation) was founded to distribute versions of the Company's products that, for marketing purposes, are sold through physicians and foreign distributors under the Polaris brand.
	The primary operating entity is DS HealthCare Group, Inc. and currently conducts its business under the "DS Laboratories" and "Divine Skin" trade names.
	In the fourth quarter of 2009, we completed an agreement with DS Laboratories Brazil, LTDA (an entity owned by an investor of the Company) to distribute our products and additional future products specifically tailored for the Brazilian market. The costs associated with procuring this agreement have been capitalized and are amortized over the life of the agreement.
	In the first quarter of 2011, we began distribution of Nutra Origin brand nutraceutical products under an exclusive distribution agreement with the manufacturer. Our Chief Executive Officer's father was part owner and COO of the manufacturer of Nutra Origin brand products.
	In the third quarter of 2011, the Company finalized discussions with DS Laboratories Brazil, LTDA, to modify its joint venture distribution agreement. In exchange for 100% ownership in the joint venture, our Brazilian distributor has fully funded the product development and licensing of our products in Brazil. We will remain the license holder once the license is granted and we retain our exclusivity for Brazilian distribution. We commenced sales in the fourth quarter 2012. As of September 30, 2013, the Company had invested $26,000 in this venture which will be repaid by our distributor.
	In the second quarter of 2012, we engaged in negotiations to license or acquire the Nutra Origin brand. Negotiations were completed and closed in the fourth quarter of 2012 whereby we pay $7,500 per month for an exclusive 10 year license to use the Nutra Origin brand. As part of the closing, we issued $50,000 in DSKX stock and granted a 7% equity interest in a newly formed subsidiary, Nutra Origin, Inc. In a separate transaction, we also acquired the 100% of the Pure Guild brand license (see Note 7).
	In the fourth quarter of 2012, we closed on the acquisition of Divine Skin Laboratories, S.A. de CV, our Mexican Distributor ("DS Mexico") (see Note 19).
	During the fourth quarter of 2012, we also completed a 10:1 reverse split and effected a name change to DS Healthcare Group, Inc. All share and per share information contained in this report gives retroactive effect to the 10:1 reverse split.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2. - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation and Presentation
	-The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.
	The consolidated financial statements include the accounts of the Company and its operating subsidiaries DS Laboratories, Inc., Sigma Development and Holding Co., Inc., Polaris Labs, Inc., Nutra Origin, Inc. and Divine Skin Laboratories, S.A. de CV. Also included in the consolidated financial statements are the activities of Velocity Storage and Packaging, LLC and Wally Group, LLC an inactive entity, which are accounted for as VIEs. All significant intercompany balances and transactions have been eliminated in consolidation.
	Interim Condensed Consolidated Financial Statements
	The interim condensed consolidated financial statements presented herein have been prepared pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The interim condensed consolidated financial statements should be read in conjunction with the Company's annual consolidated financial statements and related disclosures included in the Company's Annual Report on form 10-K, filed with the SEC on April 24, 2013. In the opinion of management, all adjustments which are necessary to provide a fair presentation of financial position as of September 30, 2013 and the related operating results and cash flows for the interim periods presented have been made. All adjustments are of a normal recurring nature. The results of operations, for the periods presented are not necessarily indicative of the results to be expected for future periods or for the year ending December 31, 2013.
	Prior Period Reclassifications
	Certain prior period amounts that were combined in the December 31, 2012 consolidated financial statements (accounts payable and accrued expenses, and shareholder loans and other current liabilities) have been reclassified for comparability with the September 30, 2013 presentation. These reclassifications had no effect on previously reported net loss.
	Use of Estimates
	The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. We believe our estimates and assumptions are reasonable; however, such estimates and assumptions are subject to a number of risks and uncertainties that may cause actual results to differ materially from such estimates. Significant estimates and assumptions underlying these consolidated financial statements include:
	·	Estimates of allowances for uncollectable accounts receivable,
	·	Estimates of inventory obsolescence and overhead and labor cost allocations,
	·	Estimates assuming future earning capacity of our exclusive Brazilian distribution agreement,
	·	Estimates of value of equity transactions for services rendered,
	·	Estimates of returned or damaged product, and
	·	Estimates made in our deferred income tax calculations.
	Risks and Uncertainties
	The Company's business could be impacted by price pressure on its product manufacturing, acceptance of its products in the market place, new competitors, changes in federal and/or state legislation and other factors. The Company also has been experiencing significant growth which puts serious strains on its cash availability requirements. If the Company is unsuccessful in securing adequate liquidity, its plans may be curtailed. Adverse changes in these areas could negatively impact the Company's financial position, results of operations and cash flows.
	Cash
	Cash equivalents include all highly liquid debt instruments with original maturities of three months or less which are not securing any corporate obligations.
	Accounts Receivable
	Accounts receivable are reported at their net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. The Company also provides for allowances against accounts receivables for product returns and cooperative advertising allowances. At September 30, 2013 and December 31, 2012, the allowance for uncollectable accounts was $544,208 and $373,981, respectively. At September 30, 2013 and December 31, 2012, the Company provided $210,000 and $110,000 respectively for defectives and product returns and $60,000 at both dates for advertising credits.
	Inventory
	Inventory is reported at the lower of cost or market on the FIFO method. Our inventory is subject to expiration and obsolescence, accordingly quantities purchased and sell through rates are periodically monitored for potential overstocking or pending expiration as a basis for establishing the appropriate reserve for any estimated expiration or obsolescence.
	Furniture and Equipment
	Furniture and equipment are recorded at cost and depreciation is provided using the straight line depreciation method over the estimated useful lives of the assets, which range from 5 to 7 years. The Company recorded $77,049 and $29,195 in depreciation expense during the nine months ended September 30, 2013 and 2012, respectively. Accumulated depreciation was $224,740 and $101,972 at September 30, 2013 and December 31, 2012, respectively. Expenditures for repairs and maintenance of equipment are charged to expense as incurred. Major replacements and betterments are capitalized and depreciated over the remaining useful lives of the assets.
	Long-Lived Assets
	The Company has adopted ASC 360-10, "Accounting for Impairment or Disposal of Long-Lived Assets", which requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.
	Long Term Debt
	Interest expense is recognized on the outstanding loan obligation as incurred and is recorded in "Interest Expense". The Company entered into a loan agreement to purchase certain warehouse equipment on December 10, 2012 (see Note 11).
	Non-Controlling Interest
	Non-controlling interest consists of the minority owned portion of the following:
	Nutra Origin, Inc. - During the fourth quarter of 2012 the Company completed its license of the Nutra Origin brand. In addition, the Company established a new subsidiary to operate the Nutra Origin brand. As part of the license agreement, the licensor was granted a 7% non-controlling interest in the newly formed subsidiary.
	Revenue Recognition
	Revenue is recognized when a product is shipped and risk of loss is transferred. The Company manages the collection process for transactions processed on its website, but it outsources its fulfillment (delivery) process to third parties.
	The Company's revenue recognition policies are in compliance with ASC Topic 605, "Revenue Recognition", which establishes criteria that must be satisfied before revenue is realized or realizable and earned. The Company recognizes revenue when all of the following four criteria are met:
	·	persuasive evidence of a sales arrangement exists,
	·	delivery has occurred,
	·	the sales price is fixed or determinable and
	·	collectability is probable.
	Shipping and handling charges related to sales transactions are recorded as sales revenues when billed to customers or included in the sales price in accordance with ASC Topic 605, "Accounting for Shipping and Handling Fees and Costs". Shipping and handling costs are included in cost of goods sold.
	Research and Development
	The Company currently maintains a functional laboratory employing two full time chemists, a part time chemist/consultant and a lab technician that identify new technology, test product alternatives and improve existing formulations. In addition, our founder and CEO devotes a substantial portion of his time in identifying new technologies and formulations to develop new products and improve existing products with the newest technology available. ASC Topic 730, "Accounting for Research and Development Costs" requires such activities be expensed in the year incurred. Such costs include laboratory supplies, salaries, materials and consultant fees. These costs are classified as product development, salaries, selling, general and administrative expenses in the condensed consolidated statements of operations, and amounted to $137,039 and $136,927 for the nine months ended September 30, 2013 and 2012, respectively.
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded when it is more likely than not that some portion or all of a deferred tax asset will not be realized,  At September 30, 2013 and 2012, a valuation allowance was provided against our deferred tax assets.  Income tax benefit is the result of Mexican operations.
	Earnings per share
	The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, "Earnings per Share". Basic earnings per share is computed by dividing net income (loss) attributable to shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. Vested warrants for 253,893 shares and vested options for 32,633 shares were excluded from the earnings per share calculation because they would be anti-dilutive.
	Segment Information
	ASC Topic 280, "Disclosures about Segments of an Enterprise and Related Information," established standards for the way that public business enterprises report information about operating segments in annual financial statements and requires those enterprises to report selected information about operating segments in interim financial reports issued to stockholders. Management has determined that the Company operates in one business segment, which is the commercialization and development of personal care products.
	Fair Value of Financial Instruments
	Fair value is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. We currently do not have any financial assets and liabilities that are recurring that would require us to disclose them at fair value.
	Functional Currency
	The U.S. dollar is the functional currency of our consolidated entities operating in the United States. The functional currency for our consolidated entity operating outside of the United States is the Mexican peso. We translate their financial statements into U.S. dollars as follows:
	·	Assets and liabilities are translated at the exchange rate in effect as of the financial statement date.
	·	Income statement accounts are translated using the weighted average exchange rate for the period.
	We include translation adjustments from currency exchange and the effect of exchange rate changes on intercompany transactions of a long-term investment nature as a separate component of shareholders' equity. There are currently no transactions of a long-term investment nature, nor any gains or losses from non-U.S. currency transactions.

LIQUIDITY

LIQUIDITY	9 Months Ended
	Sep. 30, 2013
LIQUIDITY [Abstract]	'
LIQUIDITY	'
	NOTE 3. - LIQUIDITY
	As of September 30, 2013, we had $763,957 in cash. We have sustained substantial operational losses since our inception, and such operational losses have continued through September 30, 2013. We have financed our operations primarily through the issuance of shares of our common stock, a line of credit and the issuance of promissory notes. At September 30, 2013, we had an accumulated deficit of approximately $7,366,453. The Company cannot predict how long it will continue to incur further losses or whether it will ever become profitable which is dependent upon the reduction of certain operating expenses and success of new and existing products. These conditions raise substantial doubt about the Company's ability to continue as a going concern.  Accoringly, the accompanying condensed consolidated financial statements have been prepared in conformity with US GAAP, which contemplates continuation of the Company as a going concern.  The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and carrying amount or classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. We have commenced implementing, and will continue to implement, various measures to address our financial condition, including but not limited to:
	·	Continuing to seek debt and equity financing. However, there can be no assurances that the Company will be able to raise additional capital on favorable terms, or at all.
	·	Curtailing operations where feasible to conserve cash through deferring or modifying certain of our activities until our cash flow improves and we can recommence these activities with appropriate working capital funding.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Sep. 30, 2013
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]	'
RECENT ACCOUNTING PRONOUNCEMENTS	'
	NOTE 4. - RECENT ACCOUNTING PRONOUNCEMENTS
	In February 2013, the FASB issued ASU 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income,". The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes thereto, significant amounts reclassified from accumulated other comprehensive income by the respective net income line item. This new guidance is to be applied prospectively for interim and annual periods beginning after December 15, 2012. The adoption of ASU 2013-02 did not have a material impact on the Company's unaudited condensed consolidated financial statements.
	In March 2013, FASB issued ASU 2013-05, "Foreign Currency Matters: Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity," an amendment which allows an entity to release cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. This is effective for fiscal years and interim reporting periods beginning after December 15, 2013, with early adoption permitted. We do not expect the adoption of this guidance to have a material impact on our consolidated financial statements or related disclosures.
	In July 2013, the FASB issued ASU 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,". The amendments in this update require that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except under a few limited circumstances. The amendments in this update do not require new recurring disclosures. This new guidance is to be applied prospectively for interim and annual periods beginning after December 15, 2013. The adoption of ASU 2013-11 is not expected to have a material impact on the Company's unaudited condensed consolidated financial statements.
	Management continually evaluates the potential impact, if any, of all recent accounting pronouncements on our consolidated financial statements or related disclosures and, if significant, makes the appropriate disclosures required by such new accounting pronouncements.

INVENTORY

INVENTORY	9 Months Ended
	Sep. 30, 2013
INVENTORY [Abstract]	'
INVENTORY	'
	NOTE 5. - INVENTORY
	Significant components of inventory at September 30, 2013 and December 31, 2012 consist primarily of:
		2013			2012
		(Unaudited)
	Bulk product and raw materials	$	2,110,191		$	2,402,331
	Work in process		82,773			237,284
	Merchandise inventory		870,132			1,074,833
	Inventory in transit		11,830			239,502
	Less: Allowance		(512,527	)		(500,000	)
		$	2,562,399		$	3,453,950
	Bulk product and raw materials - Bulk product consists of completed product formulations that have not yet been packaged in market ready packaging. Raw materials consist of bulk quantities of the various chemical components of our product along with bottles, pumps, labels and other packaging materials.
	Work in process - Work in process inventory consists of merchandise inventory currently in interim production stage that is partially completed and not yet market ready.
	Merchandise inventory - Merchandise inventory consists of completed formulations in market ready packaging. Our formulations are batch controlled and subject to various government regulations which, among other things, govern the purity and safety of our product.
	Inventory in transit - In transit inventory consists of primarily bulk product and raw materials where title has transferred to the Company but the inventory has yet to arrive in a designated warehouse facility either Company owned or under contract.
	Management evaluated the inventory at September 30, 2013 and December 31, 2012 and reserved $512,527 and $500,000, respectively, as an allowance for slow moving and obsolete inventory. The allowance applies primarily to bulk product and raw materials where the chemical components have expired and the bottles, pumps and packaging materials are no longer being used in current production due to packaging changes or were in excess of quantities needed based on current production consumption. Generally, merchandise inventory does not require a reserve.

PREPAID_EXPENSES_AND_OTHER_CUR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	9 Months Ended
	Sep. 30, 2013
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]	'
PREPAID EXPENSES AND OTHER CURRENT ASSETS	'
	NOTE 6. - PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets at September 30, 2013 and December 31, 2012 consist primarily of:
		2013		2012
		(Unaudited)
	Prepaid rent	$	28,620	$	21,200
	Prepaid insurance		58,138		24,304
	Deferred issuance costs, net of amortization		32,670		61,828
	Prepaid Value Added Tax		56,552		30,228
	Advances for marketing		83,362		-
	Other prepaid		863		21,604
		$	260,205	$	159,164
	Prepaid rent - Represents the temporary timing of rent payments.
	Prepaid insurance - Represents the temporary advance of deposits and scheduled premium payments made in excess of premiums expensed over the policy period. Premiums advanced and expensed during 2013-YTD totaled approximately $111,960 and $77,264, respectively.  Most of our insurance coverage was renewed in June 2013.
	Deferred issuance costs - These amounts were made in connection with obtaining financing arrangements from our asset based lender discussed more fully in Note 11, which consisted of loan origination fees, legal and due diligence fees. Deferred issuance costs advanced and expensed during 2013-YTD totaled approximately $18,750 and $47,908, respectively. Our lender charged a renewal fee in April 2013.
	Advances for marketing - Represents advances made to several marketing firms to provide consulting services thru 2013.  Advanced costs expensed during 2013-YTD totaled approximately $190,158.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2013
INTANGIBLE ASSETS [Abstract]	'
INTANGIBLE ASSETS	'
	NOTE 7. - INTANGIBLE ASSETS
	Significant components of intangible assets at September 30, 2013 and December 31, 2012 consist of:
		2013			2012
			(Unaudited)
	Distribution rights in Brazil	$	750,000		$	750,000
	Less: Accumulated amortization		(300,000	)		(243,750	)
	Net distribution rights		450,000			506,250
	Pure Guild brand rights		159,086			159,086
	Less: Accumulated amortization		(88,875	)		(77,790	)
	Net brand right		70,211			81,296
	Nutra Origin license		144,307			144,307
	Less: Accumulated amortization		-42,577			(6,500	)
	Net license		101,730			137,807
	DS Mexico Customer list		922,831			932,000
	Less: Accumulated amortization		(90,504	)		(16,945	)
	Net customer list		832,327			915,055
	Goodwill		34,444			34,444
		$	1,488,712		$	1,674,852
	Brazilian distribution rights - During 2009, the Company issued 300,000 shares of common stock to a Brazilian distributor in exchange for a 10 year exclusive distribution agreement in Brazil. The transaction was valued at $2.50 per share. The Company, through its exclusive distributor, former joint venture partner and shareholder, is currently commercializing its product line along with a generic Minoxidil product for the Brazilian market, which was introduced in the 4th quarter of 2012. $56,250 was amortized during both 2013-YTD and 2012-YTD.
	Pure Guild brand rights - During the 3rd quarter of 2009, we entered into an agreement with a customer/distributor to develop a private label brand of premium products and associated packaging materials. The Pure Guild brand of products was the result. As part of this project we obtained a 50% interest in the Pure Guild brand and the permanent exclusive rights to manufacture the Pure Guild products. In exchange for these rights, we provided $106,666 of product representing approximately 70% the initial stocking order. These rights were being amortized over 5 years, representing the basic term of the supplier agreement.
	During the second quarter of 2012, we acquired the remaining 50% ownership of the Pure Guild brand from our customer/distributor in exchange for release from the exclusive supplier agreement so that we may pursue promotion of the brand through our existing distributor network. As a convenience, we also accepted return of their remaining Pure Guild inventory, which amounted to $50,000, based on the original sales price. Because we have begun to revitalize the brands position in the market, we will modify the amortization term to appropriately reflect the remaining unamortized brand rights combined with the additional brand rights acquired, to 6 years. $11,085 and $16,495 has been amortized during 2013-YTD and 2012-YTD, respectively.
	Nutra Origin brand license - We have been distributing the Nutra Origin brand products since October 2010 and although the brand currently represents a relatively modest portion of our sales, we intend for this brand to expand our health and personal care product offerings into the nutraceutical market. Our CEO's father is a part owner and was COO of the company that owns the Nutra Origin brand. He is now our Nutra Origin product manager. Our license agreement requires us to pay $7,500 per month for an exclusive 10 year license to use the Nutra Origin brand, plus $50,000 in DSKX common shares. The agreement contains certain performance clauses for both parties, which permit cancellation by us after 3 years and permit cancellation by the seller if we fail to maintain stipulated minimum sales.  We are currently delinquent in payment of our license fees and are negotiating a modification in our license agreement.  $29, 827 has been amortized during the nine months ended September 30, 2013.
	DS Mexico Customer list - In connection with the acquisition of our Mexican distributor, which is discussed more fully in Note 19, we acquired the customer list which was recorded at its fair value as determined by management utilizing the services of an independent appraiser. The asset is being amortized over its estimated useful life of 9 years. Accordingly, the Company recognized $73,558 of amortization expense in 2013-YTD. The change in the gross value of the DS Mexico customer list is the result of foreign currency translation adjustment at September 30, 2013. At September 30, 2013 no impairment was considered necessary.
	Goodwill - Also in connection with the acquisition of our Mexican distributor, which is discussed more fully in Note 19, we acquired goodwill which represents the excess of the fair value of consideration given over the fair value of the assets acquired. Its fair value as determined by an independent appraiser. The asset is not being amortized; however the Company will access the asset for impairment annually. The change in the gross value of the goodwill is the result of foreign currency translation adjustment at September 30, 2013.  At September 30, 2013 no impairment was considered necessary.
	The following table represents the amortized cost of the various assets over the next years.
		2013			2014			2015		2016		Beyond		Total
	Asset:
	Brazil distribution rights	$	18,750		$	75,000		$	75,000	$	75,000	$	206,250	$	450,000
	Pure Guild brand rights		3,695			14,780			14,780		14,780		22,176		70,211
	Nutra Origin brand license		11,568			46,273			43,889		-		-		101,730
	Mexican Customer list		25,875			103,500			103,500		103,500		495,952		832,327
		$	59,888		$	239,553		$	237,169	$	193,280	$	724,378	$	1,454,268

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	9 Months Ended
	Sep. 30, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]	'
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	'
	NOTE 8. - ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses at September 30, 2013 and December 31, 2012 consist of:
		2013		2012
		(Unaudited)
	Trade payables	$	2,287,625	$	2,327,540
	Accrued expenses:
	Advertising and marketing	$	24,264	$	60,264
	Commissions		160,989		362,346
	Facilities		19,782		38,023
	Fees / interest		16,578		19,012
	Investor relations		52,022		44,000
	Production materials		70,692		-
	Other		-		61,807
	Personnel		82,224		109,930
	Professional fees		15,000		9,500
		$	441,551	$	704,882
	Trade payables - Consist of liabilities arising in the normal course of business, evidenced by invoices and are generally incurred in connection with the acquisition of materials, inventory or outside services. The Company has fueled its expansion in part by securing significant support from its vendors and suppliers.
	Accrued expenses - Represents commitments made for goods or services provided during 2013-QTR where the activity does not normally generate an invoice that can be recorded as a trade payable such as accrued commissions or where invoices were received subsequent to the end of the reporting period but the goods or services were provided prior to the end of the reporting period.

OTHER_CURRENT_LIABILITIES

OTHER CURRENT LIABILITIES	9 Months Ended
	Sep. 30, 2013
OTHER CURRENT LIABILITIES [Abstract]	'
OTHER CURRENT LIABILITIES	'
	NOTE 9. - OTHER CURRENT LIABILITIES
	Other current liabilities at September 30, 2013 and December 31, 2012 consist of:
		2013			2012
		(Unaudited)
	Customer deposits	$	20,312		$	22,689
	Credit cards		85,488			117,006
	Taxes payable/(receivable)		(28,891	)		78,989
	Current portion of long term debt		8,723			8,723
	Insurance premium financing		32,135			-
	Vendor financing		83,614			-
	Other		99,436			-
		$	300,817		$	227,407
	Customer deposits - represent monies advanced to us on orders for future shipments.
	Insurance premium financing - represent short term borrowings specifically to finance the acquisition of certain insurance coverage.  Our insurance coverage financed included, D&O, general liability and ocean marine coverage.
	Vendor financing - represent financing offered by vendors to fund our purchases of their product.

SHAREHOLDER_LOANS

SHAREHOLDER LOANS	9 Months Ended
	Sep. 30, 2013
SHAREHOLDER LOANS [Abstract]	'
SHAREHOLDER LOANS	'
	NOTE 10. - SHAREHOLDER LOANS
	Shareholder loans - On December 10, 2012 we received an unsecured loan for $314,000 from one of our consultants who is also a shareholder. This loan is non-interest bearing and matures on December 11, 2013. During the first quarter of 2013, we received an additional $240,000 from the same consultant/shareholder under the same terms as the initial advance, bringing the total advanced to $554,000. On September 27, 2013 the lender accepted 456,000 shares of common stock in full satisfaction of outstanding liability.  The common shares issued were valued at $843,600 based on the trading values of shares at the time of issuance.  Accordingly, the Company recognized a $289,600 loss on extinguishment of debt.
	We also received a loan from Daniel Khesin, our Chief Executive Officer for $39,000. This loan is unsecured, non-interest bearing and matures on December 25, 2013. Installment payments totaling $27,300 have been made during 2013-YTD. The net advanced outstanding at September 30, 2013 was $11,700.
	On January 20, 2013, we received an unsecured loan for $70,000 from Gamma Investors, also a shareholder and affiliate of our Brazilian distributor. The loan accrues interest at 3% per month and matures on August 20, 2013.  The loan calls for monthly installment payments along with interest. The net advanced outstanding at September 30, 2013 was $10,000.

DEBT_FINANCING

DEBT FINANCING	9 Months Ended
	Sep. 30, 2013
DEBT FINANCING [Abstract]	'
DEBT FINANCING	'
	NOTE 11. - DEBT FINANCING
	Credit Facility - On April 6, 2012 a financial institution provided the Company with a $1.5 million credit facility with an initial draw of $580,000. The credit facility provides for asset based lending collateralized by all assets of the Company. Advances are based on 70% of qualified accounts receivable and 40% of finished goods inventory. The credit facility provides for interest and bank fees, which currently aggregate to 8% (prime plus 3% plus 1.75% asset monitoring fees and other fees) per annum and expires March 24, 2014, and may be renewed under certain conditions. The credit facility is personally guaranteed by our Chief Executive Officer and, under certain conditions, may be called upon demand. The credit facility also provides for a referral fee of 4% per annum for 3 years. The Loan Agreement contains customary representations, warranties, affirmative and negative covenants and events of default. The negative covenants include, among other things, restrictions on transferring our assets, incurring additional indebtedness, engaging in mergers or acquisitions, paying dividends or making other distributions, and creating other liens on our assets, in each case subject to customary exceptions. As of September 30, 2013, the Company had $576,088 outstanding and $340,912 available to borrow based on its advance formulas for qualified accounts receivable and finished goods inventory.
	We are currently in compliance with the covenants under the credit facility, except that;
	-1
	Under the terms of the credit facility, we are required to obtain a life insurance policy on the Company's Chief Executive Officer. We have been unable to obtain the required life insurance and are currently negotiating alternative forms of collateral.
	Long Term Debt - On December 10, 2012 the Company entered into a loan agreement for $53,900 to purchase certain warehouse equipment. The loan provides for monthly payments of $1,041 for 60 months at 5.95% interest. Payments began on February 18, 2013. No interest expense from this loan was recognized in 2012 due to its immateriality.
	Principal payout over the life of the loan is as follows:
		2013		2014		2015		2016		2017		2018		Total
	Long Term Debt	$	689	$	10,073	$	10,689	$	11,343	$	12,036	$	1,036	$	45,866

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2013
COMMITMENTS AND CONTINGENCIES [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 12. - COMMITMENTS AND CONTINGENCIES
	During 2013-YTD and 2012-YTD, the Company operated under several material agreements as listed below:
	Lease for office and production facilities -
		·	The Company leased its corporate headquarters office space located in Miami Beach, Florida, on a month to month basis at $5,700 per month or $68,400 on an annual basis, which was terminated during the fourth quarter of 2012.
		·	In October 2012, the Company entered into a lease, which added 1,525 square feet of additional space and renewed its existing lease for a total of 1,875 square feet in sales facilities located in Ashville, North Carolina. The leases provide for monthly rent of $4,725 throughout the lease term which both expire on December 31, 2015.
		·	The Company leased 13,137 square feet of warehouse and production space in Pompano Beach, Florida. The lease provided for monthly rent of $6,350 and expired on October 15, 2012.
		·	In fourth quarter of 2012, the Company entered into a lease for 50,000 square feet in warehouse and corporate office space located in Deerfield Beach, Florida. The lease provides for monthly rent of $20,000 in the first six months and $27,000 per month thereafter. The lease term is for 22 months.
	The Company is committed to lease payments over the next five years are as follows:
			2013		2014		2015		2016		Beyond		Total
	Facility Leases:
	Deerfield Beach, Florida (Production) (HQ)		$	81,000	$	189,000	$	-	$	-	$	-	$	270,000
	Ashville, North Carolina (Sales)			14,174		56,695		56,695		-		-		127,564
			$	95,174	$	245,695	$	56,695	$	-	$	-	$	397,564
	Pending and threatened litigation -
	·
	The Company has received several pending and threatened litigations from various suppliers typically over non-payment for goods or services. Such vendor disputes are typical in the normal course of business. The Company has vigorously disputed those claims on the grounds of the substandard materials or services provided. In 2011, we received 5 supplier claims for certain advertising, human resource and consulting matters that we are disputing and filing counter claims. We settled four of these claims in 2012 and structured payouts representing our estimate of the amount due of $24,264 and $162,764 at September 30, 2013 and December 31, 2012, respectively.  We intend to vigorously defend the remaining claim.
	·
	On June 13, 2011, we filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an investor relations and consulting agreement entered into on or about October 15, 2010 whereby we paid a third party approximately $20,000 and 23,000 shares of restricted common stock in consideration of investor relations and consulting services. We have demanded return of the 23,000 shares of restricted stock and recovery of costs and other damages. The third party has filed a counter claim for breach of the agreement. We intend to vigorously defend this claim.
	·
	During 2011, we filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an agreement entered into on or about May 18, 2010 whereby we paid a third party approximately $500 and 20,000 shares of restricted common stock in consideration of consulting services. We have demanded return of the 20,000 shares of restricted stock and recovery of costs and other damages. The claim was dismissed for lack of jurisdiction and we re-filed the action in the Supreme Court, New York County, New York on or about January 11, 2012, seeking rescission of said agreement and the return of $500 and 20,000 shares of restricted common stock.
	·
	We and our chief executive officer, individually, were named in a lawsuit brought in the Circuit Court of the 11th Judicial Circuit in and for Miami-Dade County, Florida by a former employee of Evolution Model Management, Inc. claiming wrongful termination. We were named because we originally hired the employee rather than Evolution Model Management, as the latter was not yet an established entity. On December 2, 2012, we entered into a settlement agreement and release of claims whereby we agreed to pay the plaintiff an aggregate of $77,500, payable in three equal installments. The final payment was made in April 2013.
	·
	We and our chief executive officer, individually, were named in a lawsuit brought in the Circuit Court of the 11th Judicial Circuit in and for Miami-Dade County, Florida in 2012 by a former contractor claiming wrongful termination. Plaintiff's complaint alleges $85,000 in back salary, performance bonus and a 40,000 share grant. Management intends to vigorously defend the action and contends the suit is without merit as the contractor was dismissed for cause. Accordingly, management has not provided a contingency reserve for this matter.
	Purchase commitments
	In order to secure an adequate supply of raw materials, the Company executes purchase orders to its suppliers as evidence of its intent to purchase materials. Purchase orders outstanding at September 30, 2013 totaled $993,363.
	Contract contingencies
	Our distribution agreement with Gamma Investors, a shareholder of the Company,provides that in the event we terminate the agreement without cause, we are required to repurchase all products held in Gamma's inventory and pay Gamma a fee equal to the greater of the prior 12 month product purchased by Gamma or $2 million.  Transactions with Gamma have been de minimus to date.

EQUITY

EQUITY	9 Months Ended
	Sep. 30, 2013
EQUITY [Abstract]	'
EQUITY	'
	NOTE 13 - EQUITY
	Common Stock
	When shares are issued in lieu of cash for goods or services, such goods or services are valued based upon the shares issued multiplied by the closing price of the stock on the date immediately preceding such issuance.
	During the first quarter of 2012, the Company issued 28,182 shares for services provided by two employees valued at $3.10 - $3.20 per share, which resulted in an expense of $89,182 in aggregate. The Company also issued 8,824 shares as an award for achieving business goals. The shares were valued at $3.40, which resulted in an allowance offsetting revenues of $30,000.
	During the second quarter of 2012, the Company issued 108,764 shares for services provided by six associates valued at $2.00 - $2.80 per share, which resulted in an expense of $241,528 in aggregate. The Company also issued 38,514 shares as an award for achieving business goals at $2.60, which resulted in an allowance offsetting revenues of $100,000. In addition, a consultant exercised vested options for 40,700 common shares for $4,070.
	During the third quarter of 2012, the Company issued 28,000 shares for services provided by an IR firm and a former associate valued at $2.20 - $3.20 per share, which resulted in an expense of $69,600 in aggregate. Also during the quarter, two founders converted 450,000 shares of preferred stock into 450,000 of common shares. The Company also issued 292,000 shares to existing shareholder investors at $2.50 per share or $732,000 from which $146,400 in fees were paid to the selling agent, resulting in net proceeds of $585,600 to the Company.
	During the fourth quarter of 2012, the Company issued 31,367 shares to a distributor for achieving sales goals valued at $3.32 per share, which resulted in a sales allowance of $104,138 in aggregate. In connection with our license of the Nutra Origin brand, we issued 15,385 shares valued at $3.25 per share, which resulted in an increase in our brand rights intangible asset of $50,000.
	During the first quarter of 2013, the Company issued 15,300 shares to a distributor for achieving sales goals valued at $2.50 per share, which resulted in a sales allowance of $38,250 in aggregate. We also issued 20,000 shares to an investor relations ("IR") firm for services valued at $2.20 per share or $44,000 in total. Our directors received 5,000 shares for services valued at $3.20 per share or $16,000.
	During the second quarter of 2013, the Company issued 11,765 shares to a distributor for achieving sales goals valued at $2.11 per share, which resulted in a sales allowance of $24,824 in aggregate. We also issued 80,000 shares to an IR firm for services valued at $1.75 per share or $140,000 in total. Our directors received 7,500 shares for services valued between $1.75 and $2.61 per share or $16,350.
	During the third quarter of 2013, the Company sold an aggregate of 381,192 shares to four private investors at prices ranging from $1.00 to $1.15 per share for a total of $406,300.  Fees were paid to a third party on three of the four transactions resulting in issuance costs of $31,260.  The Company also issued 28,433 shares in aggregate, to several distributors for achieving sales goals valued at $1.50 average per share, which resulted in a sales allowance of $42,649 in aggregate. We also issued 52,700 shares in aggregate to four investor relations ("IR") firms for services valued at $1.76 average per share or $92,550 in total. We also issued 31,779 shares to two associates for services rendered valued at $1.66 average per share or $52,721 in total.
	Surrender of Common Stock
	During the third quarter of 2012, an IR firm surrendered 20,000 shares previously issued for services not fully earned and previously valued at $2.80 per share, which resulted in a return to equity of $56,000 in aggregate.
	During the fourth quarter of 2012, an IR firm returned 5,000 shares valued at $3.36 per share, which resulted in a recovery of $16,800.
	Warrants
	In fourth quarter of 2011 the Company completed a closing of a private offering of 617,857 shares of the Company's Common Stock, under a securities purchase agreement ("SPA"). The SPA provides the investors with warrants to purchase an aggregate of 154,464 shares of Common Stock. In addition, the SPA also granted warrants to purchase 49,429 shares of Common Stock as fees for assisting in the SPA closing. In addition to the foregoing, there were 50,000 warrants issued to an IR firm for services in 2010.
	The following tables present the status of all warrants outstanding at September 30, 2013 and December 31, 2012, respectively
		Warrants			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		253,893		$	4.67		4.21	$	-
	Issued		-			-				-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at December 31, 2012		253,893		$	4.67		3.21	$	-
	Exercisable at December 31, 2012		253,893		$	4.67		3.21	$	-
	Nine Months Ended September 30, 2013
	Outstanding at January 1, 2013		253,893		$	4.67		3.21	$	-
	Issued		-			-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at September 30, 2013		253,893		$	4.67		2.47	$	-
	Exercisable at September 30, 2013		253,893		$	4.67		2.47	$	-
	No warrants were issued in 2012 or 2013 to date.
	Option
	During 2009 the Company entered into a Consulting Agreement with a selling agent under which the selling agent assisted the Company in filing a registration statement on Form 10 and quotation of its shares on the Over the Counter Bulletin Board (OTCBB). The Company has issued an option to the selling agent to purchase 200,000 shares of common stock at an exercise price of $0.10 per share. At grant date, the option was valued based on the offering price of the PPM of $2.50 per share, which was $480,000. The option expires in five years. The option vests and is exercisable subject to certain lock up and leak out provisions which commence upon the effective date of the Company obtaining OTCBB listing. Leak out provisions limit exercisability of the option number to 20,000 shares per quarter. During the first quarter of 2010, the Company obtained its trading symbol and accordingly recorded an expense for consulting services of $160,000 in 2010 reflecting the structured vesting. As a result of the structured vesting, the Company recognized $128,000 in 2012 and $192,000 in 2011. At December 31, 2012 the options were fully expensed.
	The following tables present the status of all options outstanding at September 30, 2013 and December 31, 2012:
		Options			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		73,333		$	0.1		3	$	264,000
	Issued		-			-
	Exercised		(40,700	)	$	0.1
	Forfeited		-			-
	Outstanding at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Exercisable at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Nine Months Ended September 30, 2013
	Outstanding at January 1, 2013		32,633		$	0.1		2.16	$	107,690
	Issued		-			-
	Exercised		-		$	-
	Forfeited		-			-
	Outstanding at September 30, 2013		32,633		$	0.1		1.41	$	54.497
	Exercisable at September 30, 2013		32,633		$	0.1		1.41	$	54,497
	No options were issued in 2013-YTD or 2012.
	Preferred Stock
	As provided under Certificate of Designation for Series A Preferred Stock dated January 14, 2009, amended in September 2009, each share of Series A Preferred Stock is entitled to 0.2 votes per share and the Series A Preferred Stock votes together with the Company's common stock, except as otherwise provided under Florida law. The preferred stock automatically converts into common stock on a ten-to-one basis in September 2013. Two of the founders converted 4,500,000 preferred shares into 450,000 common shares during 2012. The remaining 5,500,000 shares we held by the remaining founder and CEO of the Company and converted into 550,000 common shares on September 15, 2013.

2009_EQUITY_INCENTIVE_PLAN

2009 EQUITY INCENTIVE PLAN	9 Months Ended
	Sep. 30, 2013
2009 EQUITY INCENTIVE PLAN [Abstract]	'
2009 EQUITY INCENTIVE PLAN	'
	NOTE 14. - 2009 EQUITY INCENTIVE PLAN
	Overview - The Company initiated a 2009 Equity Incentive Plan (the "Plan") to:
	1
	attract and retain the best available personnel for positions of substantial responsibility,
	2
	provide additional incentives to employees, directors and consultants, and
	3
	promote the success of the Company and the Company's affiliates.
	Options granted under the Plan may be Incentive Stock Options or Nonstatutory Stock Options, as determined by the Administrator at the time of grant. Stock Purchase Rights, time vested and/or performance vested Restricted Stock, Stock Appreciation Rights and Unrestricted Shares may also be granted under the Plan.
	Subject to the Plan - The initial maximum number of shares of Common Stock that may be issued under the Plan is 500,000 shares. No more than 100,000 Shares of Common Stock may be granted to any one Participant with respect to Options, Stock Purchase Rights and Stock Appreciation Rights during any one calendar year period. Common Stock to be issued under the Plan may be either, authorized and unissued shares or shares held in treasury.
	Eligibility - Nonstatutory Stock Options, Stock Purchase Rights, Stock Awards, Stock Appreciation Rights and Unrestricted Shares may be granted to all Service Providers. Incentive Stock Options may be granted only to Employees.
	Limitations -  Each Option shall be designated as either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, if an Employee becomes eligible in any given year to exercise Incentive Stock Options for Shares having a Fair Market Value in excess of $100,000, those Options representing the excess shall be treated as Nonstatutory Stock Options.
	Term - The term of each Option shall be stated in the applicable Option Agreement or, if not stated, ten years from the date of grant. However, in the case of an Incentive Stock Option granted to an Optionee who, at the time the Incentive Stock Option is granted, owns, directly or indirectly, stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company and any Parent or Subsidiary, the term of the Incentive Stock Option shall be five (5) years from the date of grant or such shorter term as may be provided in the applicable Option Agreement.
	Exercise and Vesting - Unless otherwise determined by the Administrator and provided for in the Option Agreement, each Option shall vest and become exercisable as to one-sixth (1/6) of the shares subject to the Option on the date that is nine months after the date of grant, and an additional one-sixth (1/6) of the shares subject to the Option every nine months thereafter until fully vested and exercisable.

SIGNIFICANT_CUSTOMERS

SIGNIFICANT CUSTOMERS	9 Months Ended
	Sep. 30, 2013
SIGNIFICANT CUSTOMERS [Abstract]	'
SIGNIFICANT CUSTOMERS	'
	NOTE 15. - SIGNIFICANT CUSTOMERS
	Our product revenues represent primarily sales of Revita, Revita Cor and Spectral DNC-N, which individually exceed 10% of total sales and collectively represent 50% of total sales. There were no other products, which individually exceed 5% of total sales. The Company sells its products to several types of customer, which primarily include distributors and salons, several of which represent individually in excess of 10% of total sales during 2013-YTD and 2012-YTD. During 2013-YTD our top ten customers generated 42% of our sales.
	There were no sales to customers individually in excess of 10% of total sales during 2013-YTD.
	Sales to customers individually in excess of 10% of total sales during 2012-YTD and their accounts receivable at September 30, 2012 were:
	Customer	Sales	Percent	Accounts	Percent
		Amount		Receivable
	B	$930,167	11%	$191,156	7%
	C	$927,518	11%	$410,831	14%

SIGNIFICANT_VENDORS

SIGNIFICANT VENDORS	9 Months Ended
	Sep. 30, 2013
SIGNIFICANT VENDORS [Abstract]	'
SIGNIFICANT VENDORS	'
	NOTE 16. - SIGNIFICANT VENDORS
	The Company purchases its raw materials from various foreign and domestic suppliers several of which represent individually in excess of 10% of total purchases. Purchases of raw materials consist primarily of basic chemicals and packaging materials. The Company believes that it enjoys cordial relationships with all its suppliers but should the need arise; the Company believes that it could transition to alternate suppliers with minimal adverse impact. It does not have any formal long term purchase agreements with its suppliers. The Company does issue purchase orders based on its production plan, which may be modified or cancelled should its production plan change.
	Purchases from significant vendors during 2013-YTD and their accounts payable at September 30, 2013 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$526,787	17%	$297,305	18%
	C	$530,515	17%	$  82,868	5%
	Purchases from significant venders during 2012-YTD and their accounts payable at September 30, 2012 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$719,638	19%	$       ---	--%
	C	$512,820	13%	$86,893	7%

GEOGRAPHIC_REVENUE_REPORTING

GEOGRAPHIC REVENUE REPORTING	9 Months Ended
	Sep. 30, 2013
GEOGRAPHIC REVENUE REPORTING [Abstract]	'
GEOGRAPHIC REVENUE REPORTING	'
	NOTE 17. - GEOGRAPHIC REVENUE REPORTING
	The Company is organized based on fundamentally one business segment although it does distribute its products on a world-wide basis. Several of its largest distributors are based in North America who in turn sell their products in Europe or Asia. We consider these customers as based in North America. However our sales to international distributors who distribute our product outside North America have been increasing. We have also recently acquired our distributor in Mexico, the results of which are more fully discussed in Note 19.
	Information about the Company's geographic operations for both 2013-YTD and 2012-YTD as follows:
		2013		2012
	Net Revenue:
	North America	$	6,888,894	$	5,858,478
	International		3,704,141		2,814,156
		$	10,593,035	$	8,672,634
	Furniture and Equipment, Net:
	North America	$	112,456	$	111,727
	International		120,068		---
		$	232,524	$	111,727

CONSOLIDATION_OF_VARIABLE_INTE

CONSOLIDATION OF VARIABLE INTEREST ENTITY	9 Months Ended
	Sep. 30, 2013
CONSOLIDATION OF VARIABLE INTEREST ENTITY [Abstract]	'
CONSOLIDATION OF VARIABLE INTEREST ENTITY	'
	NOTE 18. - CONSOLIDATION OF VARIABLE INTEREST ENTITY
	The Company holds a variable interest in Velocity Storage and Packaging LLC ("Velocity") an entity for which the Company is the primary beneficiary. Velocity performs packaging and shipping services exclusively for the Company. The Company's variable interest relates to a financing arrangement whereby, all operational expenses including labor costs, facility costs and other operational expenses are reimbursed by the Company at Velocity's cost. The Company has no equity investment in Velocity and Velocity has no assets, liabilities or equity structure of its own. Accordingly, the Company determined that Velocity was a VIE and the Company was the primary beneficiary under the guidance offered in ASC 810-10 since Velocity does not have sufficient equity at risk for the entity to finance its own activities. ASC 810-10 requires that an enterprise consolidate a VIE if that enterprise has a variable interest that will absorb a majority of the entity's expected losses if they occur.

ACQUISITION_OF_MEXICAN_DISTRIB

ACQUISITION OF MEXICAN DISTRIBUTOR	9 Months Ended
	Sep. 30, 2013
ACQUISITION OF MEXICAN DISTRIBUTOR [Abstract]	'
ACQUISITION OF MEXICAN DISTRIBUTOR	'
	NOTE 19. - ACQUISITION OF MEXICAN DISTRIBUTOR
	Effective November 1, 2012, the Company purchased essentially 100% of the outstanding common stock of Divine Skin Laboratories, S.A. DE C.V. ("DS Mexico") from the sole shareholder pursuant to a Share Exchange Agreement. In accordance with Mexican law, Mexican companies must have two shareholders therefore the principal seller will retain one share of common stock of DS Mexico.
	DS Mexico is in the business of selling, distributing and marketing the Company's products throughout Mexico. The Company acquired DS Mexico in order to obtain customers and vertically integrate its operations directly in the Mexican market.
	In consideration for the nearly 100% interest in DS Mexico, the Company issued 450,000 shares of the Company's common stock valued at $2.60 per share, based on an independent third party valuation. The Company also forgave $38,415 of invoices due from DS Mexico between April 1, 2012 and September 30, 2012. Following the closing date the sole shareholder of DS Mexico shall receive up to an aggregate of an additional 150,000 shares of DSKX Common Stock (as adjusted for a stock split, recapitalization or similar transaction) as follows:
	(i)
	50,000 shares of DSKX Common Stock in the event that annual net revenues of DS Mexico are equal to or greater than $4,000,000 during any calendar year period;
	(ii)
	50,000 shares of DSKX Common Stock in the event annual net revenues of DS Mexico are equal to or greater than $5,000,000 during any calendar year period following satisfaction of (i); and
	(iii)
	50,000 shares of DSKX Common Stock in the event annual net revenues of DS Mexico are equal to or greater than $6,000,000 during any calendar year period following satisfaction of (ii).
	In connection with the Share Exchange Agreement, the Company issued 600,000 shares of its stock, of which 450,000 shares have been delivered as of December 31, 2012. The remaining 150,000 shares are held in escrow by the Company to be delivered upon completion of the performance measures as stipulated by the Share Exchange Agreement.
	The present value of the consideration expected to be paid as part of this agreement is $1,341,015, as calculated below:
	·
	450,000 shares issued and valued at $2.60 per share, for a total of $1,170,000.
	·
	51,000 contingent shares valued at $2.60 per share, for a total of $132,600.
	·
	Forgiveness of $38,415 of invoices due from DS Mexico.
	The price per share and the estimated contingent shares to be issued in connection with this agreement were based upon a third party valuation.
	The Company incurred approximately $5,000 in professional fees in connection with its acquisition of DS Mexico in 2012.
	The following summarizes the fair value of the assets and liabilities acquired:
	Cash		$	127,321
	Accounts receivable			380,522
	Inventory			159,379
	Prepaid and other current assets			87,125
	Property and equipment, net			126,628
	Customer list			932,000
	Goodwill			34,444
	Accounts payable			(455,726	)
	Other current liabilities			(50,678	)
	Total net assets acquired		$	1,341,015
	Aggregate purchase price		$	1,341,015
	The assets acquired were recorded at preliminary estimates of fair values determined by management, based on information currently available and on current assumptions as to future operations, and were revised upon the completion of acquisition accounting and the finalization of asset valuations.
	Dr. Tamez, the former principal shareholder of DS Mexico, has agreed to oversee the day to day operations of DS Mexico in consideration of a base salary of approximately $60,000 per year. In further consideration of his employment with DS Mexico, we and Dr. Tamez entered into a performance agreement dated December 11, 2012, whereby Dr. Tamez shall receive on each 12 month anniversary of the agreement, and each year thereafter for a period of five years, such number of shares of our common stock that shall have a cumulative value of $50,000. Furthermore, during the term of Dr. Tamez's employment he shall be entitled, on a calendar year basis, to 30% of the net profits of DS Mexico (the "Profit Participation"). Commencing on the third calendar anniversary of the performance agreement with us, we shall have the option of terminating the Profit Participation in consideration of a $500,000 payment to Dr. Tamez. Furthermore, in the event that a "Change of Control" of us during the term of Dr. Tamez's employment with us, Dr. Tamez shall have the right to receive a one-time payment of $500,000. A "Change of Control" of us shall be deemed to have occurred at such time as: (1) any person (as such term is used in Section 13(d) and 14(d) of the Exchange Act) is or becomes the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act of 1934, as amended (the "Exchange Act"), directly or indirectly, of our securities representing 80% or more of the combined voting power of our outstanding securities then having the right to vote at elections of directors; (2) any person becomes the beneficial owner, directly or indirectly of, either: (i) 50% of DS Mexico's outstanding shares or (ii) 30% of DS Mexico´s shares, within a period of one year; (3) the board of directors of DS Mexico, currently consisting of Daniel Khesin, Michael Strong and Fernando Tamez, is changed in its majority; or (d) 40% of the gross value of DS Mexico´s assets is transferred to an unrelated party.
	The following unaudited pro forma information presents the combined results of operations for the three months and nine months ended September 30, 2012 as if the acquisition of Divine Skin Laboratories, S.A. DE C.V. ("DS Mexico") had been completed on January 1, 2012. The pro forma financial information includes adjustments to reflect one time charges and amortization of fair value adjustments in the appropriate pro forma periods as though the companies were combined as of the beginning of 2012. These adjustments include:
		·		An increase in amortization expense of $90,500 for the nine months ended September 30, 2012, related to the fair value of acquired identifiable intangible assets.
		·		The inclusion of compensation of $24,703 for the nine months ended September 30, 2013, primarily related to performance bonus for our general manager.
	The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may be implemented after the Acquisition:
			Three Months Ended			Nine Months Ended
			30-Sep			September 30,
			2012			2012
	Revenue		$	3,574,361		$	9,607,454
	Net income (loss)		$	(8,010	)	$	(749,973	)
	Net income (loss) per common share, basic and diluted		$	0		$	0.07

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Principles of Consolidation and Presentation	'
	Principles of Consolidation and Presentation
	-The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.
	The consolidated financial statements include the accounts of the Company and its operating subsidiaries DS Laboratories, Inc., Sigma Development and Holding Co., Inc., Polaris Labs, Inc., Nutra Origin, Inc. and Divine Skin Laboratories, S.A. de CV. Also included in the consolidated financial statements are the activities of Velocity Storage and Packaging, LLC and Wally Group, LLC an inactive entity, which are accounted for as VIEs. All significant intercompany balances and transactions have been eliminated in consolidation.
Interim Condensed Consolidated Financial Statements	'
	Interim Condensed Consolidated Financial Statements
	The interim condensed consolidated financial statements presented herein have been prepared pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The interim condensed consolidated financial statements should be read in conjunction with the Company's annual consolidated financial statements and related disclosures included in the Company's Annual Report on form 10-K, filed with the SEC on April 24, 2013. In the opinion of management, all adjustments which are necessary to provide a fair presentation of financial position as of September 30, 2013 and the related operating results and cash flows for the interim periods presented have been made. All adjustments are of a normal recurring nature. The results of operations, for the periods presented are not necessarily indicative of the results to be expected for future periods or for the year ending December 31, 2013.
Prior Period Reclassifications	'
	Prior Period Reclassifications
	Certain prior period amounts that were combined in the December 31, 2012 consolidated financial statements (accounts payable and accrued expenses, and shareholder loans and other current liabilities) have been reclassified for comparability with the September 30, 2013 presentation. These reclassifications had no effect on previously reported net loss.
Use of Estimates	'
	Use of Estimates
	The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. We believe our estimates and assumptions are reasonable; however, such estimates and assumptions are subject to a number of risks and uncertainties that may cause actual results to differ materially from such estimates. Significant estimates and assumptions underlying these consolidated financial statements include:
	·	Estimates of allowances for uncollectable accounts receivable,
	·	Estimates of inventory obsolescence and overhead and labor cost allocations,
	·	Estimates assuming future earning capacity of our exclusive Brazilian distribution agreement,
	·	Estimates of value of equity transactions for services rendered,
	·	Estimates of returned or damaged product, and
	·	Estimates made in our deferred income tax calculations.
Risks and Uncertainties	'
	Risks and Uncertainties
	The Company's business could be impacted by price pressure on its product manufacturing, acceptance of its products in the market place, new competitors, changes in federal and/or state legislation and other factors. The Company also has been experiencing significant growth which puts serious strains on its cash availability requirements. If the Company is unsuccessful in securing adequate liquidity, its plans may be curtailed. Adverse changes in these areas could negatively impact the Company's financial position, results of operations and cash flows.
Cash	'
	Cash
	Cash equivalents include all highly liquid debt instruments with original maturities of three months or less which are not securing any corporate obligations.
Accounts Receivable	'
	Accounts Receivable
	Accounts receivable are reported at their net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. The Company also provides for allowances against accounts receivables for product returns and cooperative advertising allowances. At September 30, 2013 and December 31, 2012, the allowance for uncollectable accounts was $544,208 and $373,981, respectively. At September 30, 2013 and December 31, 2012, the Company provided $210,000 and $110,000 respectively for defectives and product returns and $60,000 at both dates for advertising credits.
Inventory	'
	Inventory
	Inventory is reported at the lower of cost or market on the FIFO method. Our inventory is subject to expiration and obsolescence, accordingly quantities purchased and sell through rates are periodically monitored for potential overstocking or pending expiration as a basis for establishing the appropriate reserve for any estimated expiration or obsolescence.
Furniture and Equipment	'
	Furniture and Equipment
	Furniture and equipment are recorded at cost and depreciation is provided using the straight line depreciation method over the estimated useful lives of the assets, which range from 5 to 7 years. The Company recorded $77,049 and $29,195 in depreciation expense during the nine months ended September 30, 2013 and 2012, respectively. Accumulated depreciation was $224,740 and $101,972 at September 30, 2013 and December 31, 2012, respectively. Expenditures for repairs and maintenance of equipment are charged to expense as incurred. Major replacements and betterments are capitalized and depreciated over the remaining useful lives of the assets.
Long-Lived Assets	'
	Long-Lived Assets
	The Company has adopted ASC 360-10, "Accounting for Impairment or Disposal of Long-Lived Assets", which requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.
Long Term Debt	'
	Long Term Debt
	Interest expense is recognized on the outstanding loan obligation as incurred and is recorded in "Interest Expense". The Company entered into a loan agreement to purchase certain warehouse equipment on December 10, 2012 (see Note 11).
Non-Controlling Interest	'
	Non-Controlling Interest
	Non-controlling interest consists of the minority owned portion of the following:
	Nutra Origin, Inc. - During the fourth quarter of 2012 the Company completed its license of the Nutra Origin brand. In addition, the Company established a new subsidiary to operate the Nutra Origin brand. As part of the license agreement, the licensor was granted a 7% non-controlling interest in the newly formed subsidiary.
Revenue Recognition	'
	Revenue Recognition
	Revenue is recognized when a product is shipped and risk of loss is transferred. The Company manages the collection process for transactions processed on its website, but it outsources its fulfillment (delivery) process to third parties.
	The Company's revenue recognition policies are in compliance with ASC Topic 605, "Revenue Recognition", which establishes criteria that must be satisfied before revenue is realized or realizable and earned. The Company recognizes revenue when all of the following four criteria are met:
	·	persuasive evidence of a sales arrangement exists,
	·	delivery has occurred,
	·	the sales price is fixed or determinable and
	·	collectability is probable.
	Shipping and handling charges related to sales transactions are recorded as sales revenues when billed to customers or included in the sales price in accordance with ASC Topic 605, "Accounting for Shipping and Handling Fees and Costs". Shipping and handling costs are included in cost of goods sold.
Research and Development	'
	Research and Development
	The Company currently maintains a functional laboratory employing two full time chemists, a part time chemist/consultant and a lab technician that identify new technology, test product alternatives and improve existing formulations. In addition, our founder and CEO devotes a substantial portion of his time in identifying new technologies and formulations to develop new products and improve existing products with the newest technology available. ASC Topic 730, "Accounting for Research and Development Costs" requires such activities be expensed in the year incurred. Such costs include laboratory supplies, salaries, materials and consultant fees. These costs are classified as product development, salaries, selling, general and administrative expenses in the condensed consolidated statements of operations, and amounted to $137,039 and $136,927 for the nine months ended September 30, 2013 and 2012, respectively.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded when it is more likely than not that some portion or all of a deferred tax asset will not be realized,  At September 30, 2013 and 2012, a valuation allowance was provided against our deferred tax assets.  Income tax benefit is the result of Mexican operations.
Earnings per share	'
	Earnings per share
	The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, "Earnings per Share". Basic earnings per share is computed by dividing net income (loss) attributable to shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. Vested warrants for 253,893 shares and vested options for 32,633 shares were excluded from the earnings per share calculation because they would be anti-dilutive.
Segment Information	'
	Segment Information
	ASC Topic 280, "Disclosures about Segments of an Enterprise and Related Information," established standards for the way that public business enterprises report information about operating segments in annual financial statements and requires those enterprises to report selected information about operating segments in interim financial reports issued to stockholders. Management has determined that the Company operates in one business segment, which is the commercialization and development of personal care products.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Fair value is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. We currently do not have any financial assets and liabilities that are recurring that would require us to disclose them at fair value.
Functional Currency	'
	Functional Currency
	The U.S. dollar is the functional currency of our consolidated entities operating in the United States. The functional currency for our consolidated entity operating outside of the United States is the Mexican peso. We translate their financial statements into U.S. dollars as follows:
	·	Assets and liabilities are translated at the exchange rate in effect as of the financial statement date.
	·	Income statement accounts are translated using the weighted average exchange rate for the period.
	We include translation adjustments from currency exchange and the effect of exchange rate changes on intercompany transactions of a long-term investment nature as a separate component of shareholders' equity. There are currently no transactions of a long-term investment nature, nor any gains or losses from non-U.S. currency transactions.

INVENTORY_Tables

INVENTORY (Tables)	9 Months Ended
	Sep. 30, 2013
INVENTORY [Abstract]	'
Schedule of the Significant Components of Inventory	'
	Significant components of inventory at September 30, 2013 and December 31, 2012 consist primarily of:
		2013			2012
		(Unaudited)
	Bulk product and raw materials	$	2,110,191		$	2,402,331
	Work in process		82,773			237,284
	Merchandise inventory		870,132			1,074,833
	Inventory in transit		11,830			239,502
	Less: Allowance		(512,527	)		(500,000	)
		$	2,562,399		$	3,453,950

PREPAID_EXPENSES_AND_OTHER_CUR1

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)	9 Months Ended
	Sep. 30, 2013
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]	'
Schedule of Prepaid Expenses and Other Current Assets	'
	Prepaid expenses and other current assets at September 30, 2013 and December 31, 2012 consist primarily of:
		2013		2012
		(Unaudited)
	Prepaid rent	$	28,620	$	21,200
	Prepaid insurance		58,138		24,304
	Deferred issuance costs, net of amortization		32,670		61,828
	Prepaid Value Added Tax		56,552		30,228
	Advances for marketing		83,362		-
	Other prepaid		863		21,604
		$	260,205	$	159,164

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2013
INTANGIBLE ASSETS [Abstract]	'
Schedule of Intangible Assets	'
	Significant components of intangible assets at September 30, 2013 and December 31, 2012 consist of:
		2013			2012
			(Unaudited)
	Distribution rights in Brazil	$	750,000		$	750,000
	Less: Accumulated amortization		(300,000	)		(243,750	)
	Net distribution rights		450,000			506,250
	Pure Guild brand rights		159,086			159,086
	Less: Accumulated amortization		(88,875	)		(77,790	)
	Net brand right		70,211			81,296
	Nutra Origin license		144,307			144,307
	Less: Accumulated amortization		-42,577			(6,500	)
	Net license		101,730			137,807
	DS Mexico Customer list		922,831			932,000
	Less: Accumulated amortization		(90,504	)		(16,945	)
	Net customer list		832,327			915,055
	Goodwill		34,444			34,444
		$	1,488,712		$	1,674,852
Schedule of Future Amortization Expense for Intangible Assets	'
	The following table represents the amortized cost of the various assets over the next years.
		2013			2014			2015		2016		Beyond		Total
	Asset:
	Brazil distribution rights	$	18,750		$	75,000		$	75,000	$	75,000	$	206,250	$	450,000
	Pure Guild brand rights		3,695			14,780			14,780		14,780		22,176		70,211
	Nutra Origin brand license		11,568			46,273			43,889		-		-		101,730
	Mexican Customer list		25,875			103,500			103,500		103,500		495,952		832,327
		$	59,888		$	239,553		$	237,169	$	193,280	$	724,378	$	1,454,268

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	9 Months Ended
	Sep. 30, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]	'
Schedule of Accounts Payable and Accrued Expenses	'
	Accounts payable and accrued expenses at September 30, 2013 and December 31, 2012 consist of:
		2013		2012
		(Unaudited)
	Trade payables	$	2,287,625	$	2,327,540
	Accrued expenses:
	Advertising and marketing	$	24,264	$	60,264
	Commissions		160,989		362,346
	Facilities		19,782		38,023
	Fees / interest		16,578		19,012
	Investor relations		52,022		44,000
	Production materials		70,692		-
	Other		-		61,807
	Personnel		82,224		109,930
	Professional fees		15,000		9,500
		$	441,551	$	704,882

OTHER_CURRENT_LIABILITIES_Tabl

OTHER CURRENT LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2013
OTHER CURRENT LIABILITIES [Abstract]	'
Schedule of Other Current Liabilities	'
	Other current liabilities at September 30, 2013 and December 31, 2012 consist of:
		2013			2012
		(Unaudited)
	Customer deposits	$	20,312		$	22,689
	Credit cards		85,488			117,006
	Taxes payable/(receivable)		(28,891	)		78,989
	Current portion of long term debt		8,723			8,723
	Insurance premium financing		32,135			-
	Vendor financing		83,614			-
	Other		99,436			-
		$	300,817		$	227,407

DEBT_FINANCING_Tables

DEBT FINANCING (Tables)	9 Months Ended
	Sep. 30, 2013
DEBT FINANCING [Abstract]	'
Schedule of Long-Term Debt	'
		2013		2014		2015		2016		2017		2018		Total
	Long Term Debt	$	689	$	10,073	$	10,689	$	11,343	$	12,036	$	1,036	$	45,866

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Sep. 30, 2013
COMMITMENTS AND CONTINGENCIES [Abstract]	'
Schedule of Future Minimum Operating Lease Payments	'
	The Company is committed to lease payments over the next five years are as follows:
		2013		2014		2015		2016		Beyond		Total
	Facility Leases:
	Deerfield Beach, Florida (Production) (HQ)	$	81,000	$	189,000	$	-	$	-	$	-	$	270,000
	Ashville, North Carolina (Sales)		14,174		56,695		56,695		-		-		127,564
		$	95,174	$	245,695	$	56,695	$	-	$	-	$	397,564

EQUITY_Tables

EQUITY (Tables)	9 Months Ended
	Sep. 30, 2013
EQUITY [Abstract]	'
Schedule of Outstanding Warrant Activity	'
	The following tables present the status of all warrants outstanding at September 30, 2013 and December 31, 2012, respectively
		Warrants			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		253,893		$	4.67		4.21	$	-
	Issued		-			-				-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at December 31, 2012		253,893		$	4.67		3.21	$	-
	Exercisable at December 31, 2012		253,893		$	4.67		3.21	$	-
	Nine Months Ended September 30, 2013
	Outstanding at January 1, 2013		253,893		$	4.67		3.21	$	-
	Issued		-			-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at September 30, 2013		253,893		$	4.67		2.47	$	-
	Exercisable at September 30, 2013		253,893		$	4.67		2.47	$	-
Schedule of Outstanding Stock Option Activity	'
	The following tables present the status of all options outstanding at September 30, 2013 and December 31, 2012:
		Options			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		73,333		$	0.1		3	$	264,000
	Issued		-			-
	Exercised		(40,700	)	$	0.1
	Forfeited		-			-
	Outstanding at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Exercisable at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Nine Months Ended September 30, 2013
	Outstanding at January 1, 2013		32,633		$	0.1		2.16	$	107,690
	Issued		-			-
	Exercised		-		$	-
	Forfeited		-			-
	Outstanding at September 30, 2013		32,633		$	0.1		1.41	$	54.497
	Exercisable at September 30, 2013		32,633		$	0.1		1.41	$	54,497

SIGNIFICANT_CUSTOMERS_Tables

SIGNIFICANT CUSTOMERS (Tables)	9 Months Ended
	Sep. 30, 2013
SIGNIFICANT CUSTOMERS [Abstract]	'
Schedule of Sales to Significant Customers	'
	Sales to customers individually in excess of 10% of total sales during 2012-YTD and their accounts receivable at September 30, 2012 were:
	Customer	Sales	Percent	Accounts	Percent
		Amount		Receivable
	B	$930,167	11%	$191,156	7%
	C	$927,518	11%	$410,831	14%

SIGNIFICANT_VENDORS_Tables

SIGNIFICANT VENDORS (Tables)	9 Months Ended
	Sep. 30, 2013
SIGNIFICANT VENDORS [Abstract]	'
Schedule of Significant Purchases from Vendors	'
	Purchases from significant vendors during 2013-YTD and their accounts payable at September 30, 2013 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$526,787	17%	$297,305	18%
	C	$530,515	17%	$  82,868	5%
	Purchases from significant venders during 2012-YTD and their accounts payable at September 30, 2012 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$719,638	19%	$       ---	--%
	C	$512,820	13%	$86,893	7%

GEOGRAPHIC_REVENUE_REPORTING_T

GEOGRAPHIC REVENUE REPORTING (Tables)	9 Months Ended
	Sep. 30, 2013
GEOGRAPHIC REVENUE REPORTING [Abstract]	'
Schedule of Revenues by Geographic Area	'
	Information about the Company's geographic operations for both 2013-YTD and 2012-YTD as follows:
		2013		2012
	Net Revenue:
	North America	$	6,888,894	$	5,858,478
	International		3,704,141		2,814,156
		$	10,593,035	$	8,672,634
	Furniture and Equipment, Net:
	North America	$	112,456	$	111,727
	International		120,068		---
		$	232,524	$	111,727

ACQUISITION_OF_MEXICAN_DISTRIB1

ACQUISITION OF MEXICAN DISTRIBUTOR (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule of Purchase Price Allocation	'
	The following summarizes the fair value of the assets and liabilities acquired:
	Cash	$	127,321
	Accounts receivable		380,522
	Inventory		159,379
	Prepaid and other current assets		87,125
	Property and equipment, net		126,628
	Customer list		932,000
	Goodwill		34,444
	Accounts payable		(455,726	)
	Other current liabilities		(50,678	)
	Total net assets acquired	$	1,341,015
	Aggregate purchase price	$	1,341,015
Schedule of Pro Forma Results	'
	The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may be implemented after the Acquisition:
		Three Months Ended			Nine Months Ended
		30-Sep			September 30,
		2012			2012
	Revenue	$	3,574,361		$	9,607,454
	Net income (loss)	$	(8,010	)	$	(749,973	)
	Net income (loss) per common share, basic and diluted	$	0		$	0.07

ORGANIZATION_AND_NATURE_OF_BUS1

ORGANIZATION AND NATURE OF BUSINESS (Details) (USD $)	0 Months Ended	3 Months Ended	12 Months Ended				3 Months Ended		36 Months Ended	3 Months Ended
	Dec. 10, 2012	Dec. 31, 2012	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2013	Mar. 31, 2009	Jun. 30, 2012	Sep. 30, 2009	Jun. 30, 2012	Jun. 30, 2012
				Nutra Origin Inc. [Member]	Joint Venture with DS Laboratories Brazil LTDA [Member]	DS Laboratories Inc. [Member]	Pure Guild Brand License [Member]	Pure Guild Brand License [Member]	Pure Guild Brand License [Member]	Nutra Origin License [Member]
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'	'
Percent of outstanding shares acquired	'	'	'	'	'	100.00%	'	'	'	'
Percentage of brand license acquired	'	'	'	'	'	'	50.00%	50.00%	100.00%	'
Monthly payment amount	$1,041	'	'	'	'	'	'	'	'	$7,500
License agreement period	'	'	'	'	'	'	'	'	'	'10 years
Common stock issued for assets	'	'	2,879	'	'	'	'	'	'	50,000
Business Combination, Separately Recognized Transactions [Line Items]	'	'	'	'	'	'	'	'	'	'
Investment value in joint venture	'	'	'	'	$26,000	'	'	'	'	'
Interest in subsidiaries	'	'	'	7.00%	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'	'	'
Reverse stock split	'	'10:1 reverse split	'	'	'	'	'	'	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Provision for doubtful accounts receivable	$544,208	'	$373,981
Product return and defective reserve	210,000	'	110,000
Advertising credits	60,000	'	60,000
Depreciation expense	77,049	29,195	'
Accumulated depreciation	224,740	'	101,972
Contracted research and development expense	$137,039	$136,927	'
Minimum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Property and equipment, estimated useful life	'5 years	'	'
Maximum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Property and equipment, estimated useful life	'7 years	'	'
Stock Options [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Anti-dilutive shares from the earnings per share calculation	32,633	'	'
Warrant [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Anti-dilutive shares from the earnings per share calculation	253,893	'	'
Nutra Origin Inc. [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Interest in subsidiaries	7.00%	'	'

LIQUIDITY_Details

LIQUIDITY (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
LIQUIDITY [Abstract]	'	'	'	'
Cash	$763,957	$412,488	$945,065	$1,284,343
Accumulated deficit	($7,366,453)	($5,097,990)	'	'

INVENTORY_Details

INVENTORY (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
INVENTORY [Abstract]	'	'
Bulk product and raw materials	$2,110,191	$2,402,331
Work in process	82,773	237,284
Merchandise inventory	870,132	1,074,833
Inventory in transit	11,830	239,502
Less: Allowance	-512,527	-500,000
Inventory, net, total	$2,562,399	$3,453,950

PREPAID_EXPENSES_AND_OTHER_CUR2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]	'	'
Prepaid rent	$28,620	$21,200
Prepaid insurance	58,138	24,304
Deferred issuance cost, net of amortization	32,670	61,828
Prepaid Value Added Tax	56,552	30,228
Advances for marketing	83,362	'
Other prepaid	863	21,604
Prepaid expenses and other current assets	260,205	159,164
Advance payments towards insurance	111,960	'
Amortization of prepaid insurance	77,264	'
Deferred issuance costs	18,750	'
Amortization of financing costs	47,908	'
Advanced marketing costs expensed	$190,158	'

INTANGIBLE_ASSETS_Schedule_of_

INTANGIBLE ASSETS (Schedule of Intangible Assets) (Details) (USD $)

12 Months Ended

3 Months Ended

36 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

9 Months Ended

Dec. 31, 2012

Sep. 30, 2013

Jun. 30, 2012

Sep. 30, 2009

Jun. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Dec. 31, 2009

Sep. 30, 2009

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Pure Guild Brand License [Member]

Pure Guild Brand License [Member]

Pure Guild Brand License [Member]

Distribution Rights In Brazil [Member]

Distribution Rights In Brazil [Member]

Distribution Rights In Brazil [Member]

Distribution Rights In Brazil [Member]

Pure Guild Brand Rights [Member]

Pure Guild Brand Rights [Member]

Pure Guild Brand Rights [Member]

Pure Guild Brand Rights [Member]

Nutra Origin License [Member]

Nutra Origin License [Member]

DS Mexico Customer List [Member]

DS Mexico Customer List [Member]

Finite-Lived Intangible Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Finite-lived intangible asset, gross

'

'

'

'

'

$750,000

'

$750,000

'

'

$159,086

'

$159,086

$144,307

$144,307

$922,831

$932,000

Finite-lived intangible asset, accumulated amortization

'

'

'

'

'

-300,000

'

-243,750

'

'

-88,875

'

-77,790

-42,577

-6,500

-90,504

-16,945

Finite-lived intangible assets, net, total

'

'

'

'

'

450,000

'

506,250

'

'

70,211

'

81,296

101,730

137,807

832,327

915,055

Goodwill

34,444

34,444

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total intangible assets

1,674,852

1,488,712

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of brand rights, shares

'

'

'

'

'

'

'

'

300,000

'

'

'

'

'

'

'

'

Duration of exclusive distribution agreement

'

'

'

'

'

'

'

'

'10 years

'

'

'

'

'

'

'

'

Per share value of stock issued for purchase of intangible asset

'

'

'

'

'

'

'

'

$2.50

'

'

'

'

'

'

'

'

Amortization expense related to intangible assets

'

'

'

'

'

56,250

56,250

37,500

'

'

11,085

16,495

12,800

29,827

'

73,558

'

Product exchanged for rights

'

'

'

'

'

'

'

'

'

106,666

'

'

'

'

'

'

'

Approximate percentage of initial stocking order

'

'

'

'

'

'

'

'

'

70.00%

'

'

'

'

'

'

'

Percentage of brand license acquired

'

'

50.00%

50.00%

100.00%

'

'

'

'

'

'

'

'

'

'

'

'

Inventory

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

Amortization period of intangible asset

'

'

'

'

'

'

'

'

'

'5 years

'6 years

'

'

'

'

'9 years

'

Monthly license payments

'

'

'

'

'

'

'

'

'

'

'

'

'

7,500

'

'

'

Purchase of brand rights

$2,879

'

'

'

'

'

'

'

'

'

'

'

'

$50,000

'

'

'

INTANGIBLE_ASSETS_Schedule_of_1

INTANGIBLE ASSETS (Schedule of Future Amortization Expense for Intangible Assets) (Details) (USD $)	Sep. 30, 2013
Finite-Lived Intangible Assets [Line Items]	'
2013	$59,888
2014	239,553
2015	237,169
2016	193,280
Beyond	724,378
Amortized cost of assets	1,454,268
Distribution Rights Brazil (Exclusive) [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2013	18,750
2014	75,000
2015	75,000
2016	75,000
Beyond	206,250
Amortized cost of assets	450,000
Distribution Rights Pure Guild [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2013	3,695
2014	14,780
2015	14,780
2016	14,780
Beyond	22,176
Amortized cost of assets	70,211
Nutra Origin Brand License [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2013	11,568
2014	46,273
2015	43,889
2016	'
Beyond	'
Amortized cost of assets	101,730
DS Mexico Customer List [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2013	25,875
2014	103,500
2015	103,500
2016	103,500
Beyond	495,952
Amortized cost of assets	$832,327

ACCOUNTS_PAYABLE_AND_ACCRUED_E2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]	'	'
Trade payables	$2,287,625	$2,327,540
Accrued expenses:	'	'
Advertising and marketing	24,264	60,264
Commissions	160,989	362,346
Facilities	19,782	38,023
Fees/interest	16,578	19,012
Investor relations	52,022	44,000
Production materials	70,692	'
Other	'	61,807
Personnel	82,224	109,930
Professional fees	15,000	9,500
Accounts payable and accrued expenses, total	$441,551	$704,882

OTHER_CURRENT_LIABILITIES_Deta

OTHER CURRENT LIABILITIES (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
OTHER CURRENT LIABILITIES [Abstract]	'	'
Customer deposits	$20,312	$22,689
Credit cards	85,488	117,006
Taxes payable	-28,891	78,989
Current portion of long term debt	8,723	8,723
Insurance premium financing	32,135	'
Vendor financing	83,614	'
Other	99,436	'
Other current liabilities	$300,817	$227,407

SHAREHOLDER_LOANS_Details

SHAREHOLDER LOANS (Details) (USD $)	9 Months Ended				0 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Dec. 10, 2012	Sep. 30, 2013	Sep. 27, 2013	Sep. 30, 2013	Sep. 30, 2013
					Shareholder/Consultant [Member]	Shareholder/Consultant [Member]	Daniel Khesin [Member]	Gamma Investors [Member]
					Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]
Related Party Transaction [Line Items]	'	'	'	'	'	'	'	'
Debt instrument, face amount	'	'	'	$53,900	'	$314,000	$39,000	$70,000
Debt instrument, stated interest rate	'	'	'	5.95%	'	'	'	3.00%
Debt instrument, maturity date	'	'	'	'	'	11-Dec-13	25-Dec-13	20-Aug-13
Debt instrument, additional borrowings	'	'	'	'	'	240,000	'	'
Repayments of notes	'	'	'	'	'	'	27,300	'
Shareholder loans	21,700	'	353,000	'	'	554,000	11,700	10,000
Conversion of shareholder loans to equity, shares	'	'	'	'	456,000	'	'	'
Conversion of shareholder loans to equity	843,600	'	'	'	843,600	'	'	'
Loss on extinguishment of debt	$289,600	'	'	'	$289,600	'	'	'

DEBT_FINANCING_Details

DEBT FINANCING (Details) (USD $)	0 Months Ended
	Dec. 10, 2012	Apr. 06, 2012	Sep. 30, 2013
DEBT FINANCING [Abstract]	'	'	'
Credit facility maximum borrowing capacity	'	$1,500,000	'
Credit facility amount outstanding	'	580,000	576,088
The percentage of total finished goods inventory that determines the amount of allowable advances under the credit facility	'	40.00%	'
Credit facility interest rate	'	8.00%	'
Prime interest rate spread	'	3.00%	'
Percentage rate for monitoring and other fees per terms of credit facility agreement	'	1.75%	'
The per annum referral fee percentage rate per terms of credit facility agreement	'	4.00%	'
Number of years referral fee is in effect	'	'3 years	'
Additional amount that can be borrowed on facility	'	'	340,912
Debt instrument, face amount	53,900	'	'
Monthly payment amount	$1,041	'	'
Debt instrument, stated interest rate	5.95%	'	'

DEBT_FINANCING_Schedule_of_the

DEBT FINANCING (Schedule of the Principal Payout of Debt) (Details) (USD $)	Sep. 30, 2013
DEBT FINANCING [Abstract]	'
2013	$689
2014	10,073
2015	10,689
2016	11,343
2017	12,036
2018	1,036
Total long-term debt	$45,866

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Leases for Office and Production Facilities) (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2013	Oct. 31, 2012	Sep. 30, 2013
		Miami Beach, FL (HQ) [Member]	Deerfield Beach, Florida (Production) [Member]	Deerfield Beach, Florida (Production) [Member]	Pompano, FL (Production) [Member]	Ashville, North Carolina (Sales) [Member]	Ashville, North Carolina (Sales) [Member]
			sqft		sqft	sqft
Operating Leased Assets [Line Items]	'	'	'	'	'	'	'
Operating leases, rent expense, monthly, net	'	$5,700	'	'	$6,350	$4,725	'
Operating leases, rent expense, annually, net	'	68,400	'	'	'	'	'
Area of real estate space	'	'	50,000	'	13,137	1,875	'
Increase amount of real estate acquired	'	'	'	'	'	1,525	'
Operating leases, rent expense, monthly, net, during first year	'	'	27,000	'	'	'	'
Operating leases, rent expense, monthly , first six months	'	'	20,000	'	'	'	'
Operating lease renewal option extended period	'	'	'22 months	'	'	'	'
2013	95,174	'	'	81,000	'	'	14,174
2014	245,695	'	'	189,000	'	'	56,695
2015	56,695	'	'	'	'	'	56,695
2016	'	'	'	'	'	'	'
Beyond	'	'	'	'	'	'	'
Total	$397,564	'	'	$270,000	'	'	$127,564

COMMITMENTS_AND_CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Pending and Threatened Litigation, Purchase Commitments and Contract Contingencies) (Details) (USD $)	0 Months Ended	9 Months Ended	12 Months Ended			9 Months Ended
	Jun. 13, 2011	Sep. 30, 2013	Dec. 31, 2011	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013
				Suppliers [Member]	Suppliers [Member]	Related Party Former Employee Litigation [Member]
Loss Contingencies [Line Items]	'	'	'	'	'	'
Accrued value of loss contingency	'	'	'	$24,264	$162,764	$77,500
Possible liability	'	'	'	'	'	85,000
Amount paid for prior services	20,000	'	500	'	'	'
Litigation for recission, number of shares	23,000	'	20,000	'	'	40,000
Long-term Purchase Commitment [Line Items]	'	'	'	'	'	'
Purchase orders outstanding	'	$993,363	'	'	'	'

EQUITY_Common_Stock_Details

EQUITY (Common Stock) (Details) (USD $)	3 Months Ended							12 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2012
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Stock issued as compensation for service	'	'	'	'	28,000	108,764	28,182	'
Issuance of common stock, per share	'	'	'	'	$2.50	'	'	'
Issuance of common stock for services	'	'	'	'	$69,600	$241,528	$89,182	'
Exercised	'	'	'	'	732,000	4,070	'	4,070
Exercised, shares	'	'	'	'	292,000	40,700	'	'
Employee/associate compensation, per share	$1.50	$2.11	$2.50	$3.32	'	$2.60	$3.40	'
Employee/associate compensation, shares	28,433	11,765	15,300	31,367	'	38,514	8,824	'
Revenue allowance	42,649	24,824	38,250	104,138	'	100,000	30,000	'
Stock surrendered, value	'	'	'	'	'	'	'	16,800
Professional fees	'	'	'	'	146,400	'	'	'
Net proceeds from issuance of common stock	'	'	'	'	585,600	'	'	'
Two Founders [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Conversion of preferred stock to common stock, shares	'	'	'	'	450,000	'	'	'
Nutra Origin License [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Stock issued as compensation for service	'	'	'	15,385	'	'	'	'
Issuance of common stock, per share	'	'	'	$3.25	'	'	'	'
Increase in intangible assets	'	'	'	-50,000	'	'	'	'
IR Firm [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Stock issued as compensation for service	52,700	80,000	20,000	'	'	'	'	'
Issuance of common stock, per share	$1.76	$1.75	$2.20	$3.36	$2.80	'	'	'
Issuance of common stock for services	92,550	140,000	44,000	'	'	'	'	'
Stock surrendered, shares	'	'	'	5,000	20,000	'	'	'
Stock surrendered, value	'	'	'	16,800	56,000	'	'	'
Directors [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Stock issued as compensation for service	'	7,500	5,000	'	'	'	'	'
Issuance of common stock, per share	'	'	$3.20	'	'	'	'	'
Issuance of common stock for services	'	16,350	16,000	'	'	'	'	'
Four Private Investors [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Employee/associate compensation, shares	381,192	'	'	'	'	'	'	'
Share based compensation expense	31,260	'	'	'	'	'	'	'
Net proceeds from issuance of common stock	406,300	'	'	'	'	'	'	'
Two Associates [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Stock issued as compensation for service	31,779	'	'	'	'	'	'	'
Issuance of common stock, per share	$1.66	'	'	'	'	'	'	'
Issuance of common stock for services	$52,721	'	'	'	'	'	'	'
Minimum [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Issuance of common stock, per share	'	'	'	'	$2.20	$2.80	$3.10	'
Minimum [Member] | Directors [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Issuance of common stock, per share	'	$1.75	'	'	'	'	'	'
Minimum [Member] | Four Private Investors [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Employee/associate compensation, per share	$1	'	'	'	'	'	'	'
Maximum [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Issuance of common stock, per share	'	'	'	'	$3.20	$3.20	$3.20	'
Maximum [Member] | Directors [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Issuance of common stock, per share	'	$2.61	'	'	'	'	'	'
Maximum [Member] | Four Private Investors [Member]	'	'	'	'	'	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Employee/associate compensation, per share	$1.15	'	'	'	'	'	'	'

EQUITY_Warrants_Details

EQUITY (Warrants) (Details) (USD $)	9 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended	3 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2012
			Warrant [Member]	Warrant [Member]	Warrant [Member]
					Common Stock Securities Purchase Agreement [Member]
Stockholders Equity Note [Line Items]	'	'	'	'	'
Shares issued, shares	'	'	'	'	617,857
Warrants available to purchase, shares	'	'	'	'	49,429
Qualified warrants	'	'	'	'	154,464
Issued for financial consulting services	'	'	'	'	$50,000
Warrants	'	'	'	'	'
Outstanding, beginning balance	'	'	253,893	253,893	'
Issued	'	'	'	'	'
Exercised	'	40,700	'	'	'
Forfeited	'	'	'	'	'
Exercisable	'	'	253,893	253,893	'
Outstanding, ending balance	'	'	253,893	253,893	'
Weighted average exercise price	'	'	'	'	'
Outstanding, beginning balance	'	'	$4.67	$4.67	'
Issued	'	'	'	'	'
Exercised	'	'	'	'	'
Forfeited	'	'	'	'	'
Exercisable	'	'	$4.67	$4.67	'
Outstanding, ending balance	'	'	$4.67	$4.67	'
Weighted average remaining contractual term	'	'	'	'	'
Outstanding, beginning balance	'	'	'3 years 2 months 16 days	'4 years 2 months 16 days	'
Exercisable	'	'	'2 years 5 months 19 days	'3 years 2 months 16 days	'
Outstanding, ending balance	'	'	'2 years 5 months 19 days	'3 years 2 months 16 days	'
Aggregate intrinsic value	'	'	'	'	'
Outstanding, beginning balance	'	'	'	'	'
Issued	'	'	'	'	'
Exercisable	'	'	'	'	'
Outstanding, ending balance	'	'	'	'	'

EQUITY_Stock_Options_Details

EQUITY (Stock Options) (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Options	'	'	'	'
Outstanding, beginning	32,633	73,333	'	'
Issued	'	'	'	'
Exercised	'	-40,700	'	'
Forfeited	'	'	'	'
Outstanding, ending	32,633	32,633	73,333	'
Weighted average exercise price, beginning	$0.10	$0.10	'	'
Weighted average exercise price, issued	'	'	'	'
Weighted average exercise price, exercised	'	$0.10	'	'
Weighted average exercise price, forfeited	'	'	'	'
Weighted average exercise price, ending	$0.10	$0.10	$0.10	'
Weighted average remaining contractual term	'1 year 4 months 28 days	'2 years 2 months	'3 years	'
Options outstanding, Aggregate beginning balance	$107,690	$264,000	'	'
Options outstanding, Aggregate ending balance	54,497	107,690	264,000	'
Options exercisable	32,633	32,633	'	'
Options exercisable, weighted average exercise price	$0.10	$0.10	'	'
Options exercisable, weighted average remaining contractual term	'1 year 4 months 28 days	'2 years 2 months	'	'
Options exercisable, intrinsic value	54,497	107,690	'	'
Vested for trading symbol	'	128,000	'	'
Issuance of Equity Private Placement Memorandum [Member]	'	'	'	'
Options	'	'	'	'
Price per share	$2.50	'	'	'
Grant date fair value	480,000	'	'	'
Exercisable number of shares per quarter, maximum	20,000	'	'	'
Consulting Agreement [Member]	'	'	'	'
Options	'	'	'	'
Price per share	$0.10	'	'	'
Exercisable number of shares per quarter, maximum	200,000	'	'	'
Vested for trading symbol	'	$128,000	$192,000	$160,000

EQUITY_Preferred_Stock_Details

EQUITY (Preferred Stock) (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
EQUITY [Abstract]	'	'
Number of voting rights per share of Series A Preferred Stock	0.2	'
Conversion of preferred stock into common stock	5,500,000	4,500,000
Preferred stock, shares outstanding	0	5,500,000
Conversion of convertible debt into common shares	550,000	450,000

2009_EQUITY_INCENTIVE_PLAN_Det

2009 EQUITY INCENTIVE PLAN (Details) (2009 Equity Incentive Plan [Member], USD $)	9 Months Ended
	Sep. 30, 2013
2009 Equity Incentive Plan [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares authorized under plan	500,000
Maximum number of shares issuable to one employee during one calendar year	100,000
The fair market value threshold, that if achieved by option holders, will cause any excess options to be treated as Nonstatutory Stock Options	$100,000
Term of Option, unless otherwise stated in Option Agreement (in years)	'10 years
The term for options held by holders of more than 10% of the total combined voting power of all classes of stock of the Company and any Parent or Subsidiary (in years)	'5 years

SIGNIFICANT_CUSTOMERS_Details

SIGNIFICANT CUSTOMERS (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Concentration Risk [Line Items]	'	'	'	'	'
Sales Amount	$3,338,751	$3,348,016	$11,422,939	$9,261,091	'
Accounts Receivable	1,802,262	2,575,231	1,802,262	2,575,231	2,125,641
Customer B [Member] | Accounts Receivable [Member]	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Accounts Receivable	'	191,156	'	191,156	'
Concentration risk percentage	'	'	'	7.00%	'
Customer B [Member] | Sales Amount [Member]	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Sales Amount	'	'	'	930,167	'
Concentration risk percentage	'	'	'	11.00%	'
Customer C [Member] | Accounts Receivable [Member]	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Accounts Receivable	'	410,831	'	410,831	'
Concentration risk percentage	'	'	'	14.00%	'
Customer C [Member] | Sales Amount [Member]	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Sales Amount	'	'	'	$927,518	'
Concentration risk percentage	'	'	'	11.00%	'
Revita, Revita Cor and Spectral DNC-N [Member] | Sales Amount [Member]	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Concentration risk percentage	'	'	50.00%	'	'
Top Ten Customers [Member] | Sales Amount [Member]	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Concentration risk percentage	'	'	42.00%	'	'

SIGNIFICANT_VENDORS_Details

SIGNIFICANT VENDORS (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
			Vendor A [Member]	Vendor A [Member]	Vendor A [Member]	Vendor A [Member]	Vendor C [Member]	Vendor C [Member]	Vendor C [Member]	Vendor C [Member]
			Purchase Amount [Member]	Purchase Amount [Member]	Accounts Payable [Member]	Accounts Payable [Member]	Purchase Amount [Member]	Purchase Amount [Member]	Accounts Payable [Member]	Accounts Payable [Member]
Concentration Risk [Line Items]	'	'	'	'	'	'	'	'	'	'
Purchase Amount	'	'	$526,787	$719,638	'	'	$530,515	$512,820	'	'
Concentration risk percentage	'	'	17.00%	19.00%	18.00%	'	17.00%	13.00%	5.00%	7.00%
Accounts payable	$2,287,625	$2,327,540	'	'	$297,305	'	'	'	$82,868	$86,893

GEOGRAPHIC_REVENUE_REPORTING_D

GEOGRAPHIC REVENUE REPORTING (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Segment Reporting Information [Line Items]	'	'	'	'	'
Sales Revenues Goods, Net	$3,200,189	$3,190,390	$10,593,035	$8,672,634	'
Furniture and Equipment, net	232,524	111,727	232,524	111,727	293,720
North America [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Sales Revenues Goods, Net	'	'	6,888,894	5,858,478	'
Furniture and Equipment, net	112,456	111,727	112,456	111,727	'
International [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Sales Revenues Goods, Net	'	'	3,704,141	2,814,156	'
Furniture and Equipment, net	$120,068	'	$120,068	'	'

ACQUISITION_OF_MEXICAN_DISTRIB2

ACQUISITION OF MEXICAN DISTRIBUTOR (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Subsequent Event [Line Items]	'	'	'
Professional fees	$146,400	'	'
Increase in amortization expense related to fair value of acquired identifiable intangible assets	'	'	90,500
Compensation related to performance bonus for general manager	'	24,703	'
Dr. Tamez [Member]	'	'	'
Subsequent Event [Line Items]	'	'	'
Annual salary	'	60,000	'
Value of annual equity award	'	50,000	'
Profit sharing, percent of profits	'	30	'
Profit participation termination contingent payment	'	500,000	'
Contingent payment, change in control	'	500,000	'
DS Laboratories S. A. DE C. V. [Member]	'	'	'
Subsequent Event [Line Items]	'	'	'
Percentage of business acquired	'	100.00%	'
Number of shares issued for business acquisition	'	450,000	'
Per share value issued, business combination	'	$2.60	'
Debt forgiveness by company	'	38,415	'
Equity Instruments delivered, value	'	1,170,000	'
Purchase Mexican distributor, shares	'	600,000	'
Additional shares of common stock issued	'	150,000	'
Contingent shares issuable, shares	'	51,000	'
Contingent consideration, liability	'	132,600	'
Cash	'	127,321	'
Accounts receivable	'	380,522	'
Inventory	'	159,379	'
Prepaid and other current assets	'	87,125	'
Property and equipment, net	'	126,628	'
Customer list	'	932,000	'
Goodwill	'	34,444	'
Accounts payable	'	-455,726	'
Other current liabilities	'	-50,678	'
Total assets acquired	'	1,341,015	'
Aggregate purchase price	'	1,341,015	'
Professional fees	'	5,000	'
DS Laboratories S. A. DE C. V. [Member] | Net Revenues Equal or Greater than $4,000,000 [Member]	'	'	'
Subsequent Event [Line Items]	'	'	'
Purchase Mexican distributor, shares	'	50,000	'
Revenues, net	'	4,000,000	'
DS Laboratories S. A. DE C. V. [Member] | Net Revenues Equal or Greater than $5,000,000 [Member]	'	'	'
Subsequent Event [Line Items]	'	'	'
Purchase Mexican distributor, shares	'	50,000	'
Revenues, net	'	5,000,000	'
DS Laboratories S. A. DE C. V. [Member] | Net Revenues Equal or Greater than $6,000,000 [Member]	'	'	'
Subsequent Event [Line Items]	'	'	'
Purchase Mexican distributor, shares	'	50,000	'
Revenues, net	'	$6,000,000	'

ACQUISITION_OF_MEXICAN_DISTRIB3

ACQUISITION OF MEXICAN DISTRIBUTOR (Schedule of Pro Forma Results) (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2012
ACQUISITION OF MEXICAN DISTRIBUTOR [Abstract]	'	'
Revenue	$3,574,361	$9,607,454
Net income (loss)	($8,010)	($749,973)
Net income (loss) per common share, basic and diluted	$0	$0.07